abstract front oncol oct

establishment clinical cancer genetics program breast cancer resourcelimited country challenge opportunity

abdelrazeq h sharaf b tamimi f hani hb alsmadi khalil h abunasser edaily mansour

department internal medicine king hussein cancer center amman jordan school medicine university jordan amman jordan department cell therapy applied genomics king hussein cancer center amman jordan department radiology king hussein cancer center amman jordan

breast cancer common cancer among woman worldwide incidence rate still increasing especially among younger woman nationally constitutes onefifth cancer case almost female cancer median age year breast cancer diagnosed least decade earlier advanced stage compared western society hereditary cancer account cancer burden worldwide expanded indication increased number gene tested significant decline cost testing proportion probably increase individual pathogenic variant brca brca higher risk breast ovarian pancreatic many cancer past two decade several highly penetrant cancersusceptibility gene identified across almost tumor site thus increasing need comprehensive cancer genetic program address testing process counselling patient atrisk family member deal testing result consequence addition important role preventing cancer index patient among close relative identification pathogenic likely pathogenic variant mostly brca brca may inform therapeutic decision common cancer including breast ovarian prostate pancreatic cancer manuscript describe experience comprehensive cancer center resourcelimited country establishing comprehensive clinical cancer genetics program serve example others share similar demographic financial restrains

copyright abdelrazeq sharaf tamimi hani alsmadi khalil abunasser edaily mansour

doi fonc pmcid pmc

conflict interest statement author declare research conducted absence commercial financial relationship could construed potential conflict interest

abstract appl immunohistochem mol morphol novdec doi pai epub nov

pilot study brca pik mutation across subtypes triple negative breast cancer north indian population

gupta p thakur chadda irinike khare bal

department histopathology general surgery postgraduate institute medical education research pgimer chandigarh punjab india

brca tumor suppressor gene regulate dna repair mechanism mutation brca may increase risk breast cancer patient present study frequency brca mutation triple negative breast cancer tnbc patient assessed correlated molecular subtypes tnbc blood sample confirmed case tnbc collected dna isolated whole blood library prepared using brca custom panel sequencing done ion torrent sequencer ion reporter used data analysis molecular subtyping mutation positive tnbc case done using immunohistochemistry marker ck ck vimentin ecadherin androgen receptor ar using tissue microarray twenty five patient heterozygous pathogenic mutation alteration conflicting interpretation pathogenicity variant uncertain significance variant unknown significance nine patient pathogenic mutation brca gene patient pathogenic mutation brca gene two patient transheterozygous brca mutation pathogenic mutation brca gene simultaneously compound heterozygous involving brca gene case prevalent subtypes among brca positive case unclassified subtype n basal like n mesenchymal subtype n none lar subtype showed brca mutation present study observed brca mutation frequent brca mutation tnbc brca mutation correspond brcaness basal phenotype considering high incidence breast cancer lack correlation basal morphology brca mutation molecular method used screening brca mutation help familial screening also deciding targeted therapy parp polyadp ribose polymerase inhibitor

copyright wolters kluwer health inc right reserved

doi pai indexed medline

conflict interest statement author declare conflict interest

abstract dna repair amst nov online ahead print

oneended twoended break nickasebroken replication fork

scully r walter jc nussenzweig

department medicine division hematologyoncology cancer research institute beth israel deaconess medical center harvard medical school boston usa electronic address rscullybidmcharvardedu department biological chemistry molecular pharmacology blavatnik institute harvard medical school boston usa howard hughes medical institute boston usa laboratory genome integrity national cancer institute nih bethesda md usa

replisome collision nicked parental dna template lead formation replicationassociated double strand break dsb break repaired implication cancer initiation cancer therapy therapeutic gene editing recent work show collision replisome nicked dna template give rise either singleended se doubleended dedsb potentially divergent effect repair pathway choice genomic instability emerging evidence suggests biochemical environment broken mammalian replication fork may specialized way skew repair favor homologous recombination expense nonhomologous end joining

copyright published elsevier bv

doi jdnarep

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract obstet gynecol int oct

brca protein expression epithelial ovarian cancer associated clinicopathological factor uganda

okecha abila db nabbale dl katongole f yahaya jj lukande r kalungi nalwoga h

department pathology uganda cancer institute kampala uganda department pathology uganda christian university kampala uganda department pathology college health science makerere university kampala uganda department pathology mulago national referral hospital kampala uganda department pathology busitema university mbale uganda department pathology school health science soroti university soroti uganda

background brca gene dysfunction seen epithelial ovarian carcinoma often result germline mutation somatic mutation promoter methylation identification tumor loss brca protein expression shown therapeutic prognostic implication aim study determine expression brca protein epithelial ovarian cancer eoc associated clinicopathological characteristic method result crosssectional laboratorybased study used paraffinembedded tissue block patient histologically diagnosed eoc january august tissue section stained hematoxylin eosin histological confirmation immunohistochemistry ihc using mousederived monoclonal antibody m brca protein expression association brca protein expression independent variable determined using pearsons chisquare test total tissue block patient eoc included study mean age year serous tumor common comprised tumor majority high grade loss expression brca protein expression found case statistically significant association brca expression age patient tumor grade histological subtype conclusion high expression altered brca expression tissue eoc although shown association age patient histology type tumor grade study need ass influence survival cancer patient eoc

copyright tonny okecha et al

doi pmcid pmc

conflict interest statement author declare conflict interest

abstract cancer control jandec doi

update combination strategy parp inhibitor

lin z wang l xing z wang f cheng x

woman hospital zhejiang university school medicine hangzhou china zhejiang key laboratory precision diagnosis therapy major gynecological disease woman hospital zhejiang university school medicine hangzhou pr china gynecological oncology department woman hospital zhejiang university school medicine hangzhou pr china zhejiang provincial clinical research center obstetrics gynecology hangzhou pr china zhejiang key laboratory precision diagnosis therapy major gynecological disease hangzhou pr china

application parp inhibitor revolutionized cancer treatment achieved significant advancement particularly regard tumor defect gene involved homologous recombination repair hrr process brca brca despite promising outcome parp inhibitor certain limitation challenge still exist including acquired drug resistance severe side effect limited therapeutic benefit patient without homologous recombination deficiency hrd various combination involving parp inhibitor developed overcome limitation among combination immune checkpoint inhibitor antiangiogenic agent various smallmolecule inhibitor wellstudied strategy show great potential optimizing efficacy parp inhibitor overcoming resistance mechanism expanding target population however efficiency overlapping toxicity combination strategy cancer vary among study thereby limiting use review describe mechanism limitation parp inhibitor better understand mechanism combination treatment furthermore summarized recent study combination parp inhibitor range medication discussed clinical efficacy objective review enhance comprehensiveness information pertaining topic

doi pmcid pmc indexed medline

conflict interest statement declaration conflicting intereststhe author declared potential conflict interest respect research authorship andor publication article

abstract nar genom bioinform nov lqae

tumor purity estimated bulk dna methylation used adjusting beta value individual sample better reflect tumor biology

sasiain nacer df aine veerla staaf j

division translational cancer research department laboratory medicine lund university lund sweden division oncology department clinical science lund lund university lund sweden

epigenetic deregulation altered dna methylation fundamental feature tumorigenesis tumor data bulk tissue sample contain different proportion malignant nonmalignant cell may confound interpretation dna methylation value adjustment dna methylation data based tumor purity proposed render genomewide genespecific analysis precise requires sample purity estimate present purebeta singlesample statistical framework us genomewide dna methylation data first estimate sample purity adjust methylation value individual cpgs correct sample impurity purity value estimated algorithm high correlation reference value obtained dna sequencing applied sample breast carcinoma lung adenocarcinoma lung squamous cell carcinoma methylation beta value adjusted based purity estimate binary distribution better reflects theoretical methylation state thus facilitating improved biological inference shown brca breast cancer purebeta versatile tool used different illumina dna methylation array applied individual sample different cancer type enhance biological interpretability methylation data

author published oxford university press behalf nar genomics bioinformatics

doi nargablqae pmcid pmc

abstract environ mol mutagen jul

correction mutation spectrum brca gene human breast ovarian cancer germline

author listed

erratum environ mol mutagen jun

doi em

abstract int j biol macromol oct online ahead print

silico screening identifying phytoconstituents withania somnifera potent inhibitor brca mutant therapeutic breast cancer

panda sm nandeshwar tripathy u

department physic indian institute technology indian school mine dhanbad jharkhand india department physic indian institute technology indian school mine dhanbad jharkhand india electronic address utripathyiitismacin

breast cancer gene brca antioncogene help cell repair damaged dna preserve genetic material brca also act cell growth suppressor produce tumor suppressor gene tsg protein ie brca protein remarkably brca mutation account hereditary breast cancer majority hereditary ovarian cancer hence considered three mutant brca rw rq ta study adopted insilico approach find best possible phytochemical inhibit mutated protein enabling early breast cancer diagnosis perceiving importance many natural molecule ancient medicinal plant considered molecular docking finding suggest though many molecule bind actively receptor active site top three phytoconstituents deoxyhydroxywithaferin withacoagulin somniferanolide withania somnifera commonly known ashwagandha high binding affinity suitable pharmacokinetic property making natural compound potential drug candidate molecular dynamic md simulation binding free energy calculation show stability thermodynamically favourable therefore draw conclusion lead compound act potential inhibitor brca however wet lab experiment clinical trial recommended ascertain efficacy hence development novel brca inhibitor

copyright published elsevier bv

doi jijbiomac

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract oncol lett oct dec

biomarkers predict benefit immunecheckpoint blockadebased therapy patient malignant peritoneal mesothelioma review

wang c zhao liang w

department hematology oncology second hospital jilin university changchun jilin pr china

malignant peritoneal mesothelioma mpem type rare highly lethal tumor immune checkpoint blockade icbbased therapy shown encouraging clinical activity mpem however definitive biomarkers identified predicting patient mpem benefit icbbased therapy present several novel potential biomarkers proposed predicting response icbbased therapy biomarkers available mpem cell tumor microenvironment identified potential predict efficacy icbbased therapy mpem according molecular characteristic mpem feasibility biomarkers practice body available evidence hypothesize following five type biomarkers used predict response icbbased therapy patient mpem tertiary lymphoid structure immune checkpoint ligand fusion gene neoantigen burden brcaassociated protein haploinsufficiency transcriptomebased biomarkers present review discus value limitation type biomarker potential solution address limitation proposed aim present review provide background future study icbbased therapy mpem

copyright wang et al

doi ol pmcid pmc

conflict interest statement author declare competing interest

abstract sci rep nov

silico approach uncovering competency oncolytic human adenovirus targeted breast cancer virotherapy

naveed batool z aziz javed k ali n rehman hm alharbi alasmari af alshammari

department biotechnology faculty science technology university central punjab lahore pakistan naveedquaidiangmailcom department biotechnology faculty science technology university central punjab lahore pakistan laboratory animal health food hygiene quality university ioannina arta greece school biochemistry biotechnology university punjab lahore pakistan department pharmacology toxicology college pharmacy king saud university riyadh saudi arabia department pharmacology toxicology college pharmacy king saud university riyadh saudi arabia iwockdgmailcom

breast cancer remains major health threat throughout world specifically woman year age however rarely known affect men well characterized abnormal division cell breast tissue resulting development breast malignancy various risk factor contributing breast cancer include age family history genetic mutation chiefly brca brca gene along hormonal imbalance oestrogen progesterone early detection obtained frequent round selfexamination mammographic scanning clinical assessment play crucial role prevention disease addition appropriate diagnosis assist better therapeutic response study highlight considerable health risk associated conventional treatment procedure arise increased demand advanced secure riskfree treatment alternative oncolytic virus potentially apparent aim improving cancer therapeutic reduced side effect virus act fundamental therapeutic agent selectively target kill malignant cell without harm healthy tissue key objective research provide evidence human adenovirus potent oncolytic virus highlight capacity target eliminate cancer cell precision causing least amount harm healthy tissue validating insilico method entail evaluating precision dependability computational modelling contrasting insilico prediction finding experiment rank secondary objective workflow research utilized insilico computational drug designing approach including retrieval tertiary structure target breast cancer type susceptibility protein brca viral human adenovirus protein validation generating ramachandran plot determining favoured amino acid residue angle prediction active residue furthermore study focused molecular dynamic docking protein interpretation molecular interaction docked complex well assessment molecular dynamic simulation md addition mmgbsa binding energy calculation successful docking brca adenovirus protein provided significant score furthermore md simulation showed high rmsd peak rmsf maximum highest proteinprotein interaction radius gyration stable throughout simulation representing elastic stability along high energy interaction value kcalmol moreover mmgbsa calculation result showed notable release binding free energy kcalmol demonstrating effective bond formation docked complex finding propose effectiveness human adenovirus treat cancer selected oncolytic human adenovirus potential candidate target specific treatment breast cancer virotherapy computeraided drug discovery present significant potential targeting cancer cell would assist development potent drug reagent cancer therapy

author

doi pmcid pmc indexed medline

conflict interest statement author declare competing interest

abstract adv med sci oct doi jadvms online ahead print

recurrent hepatocellular carcinoma associated enrichment myc target gene set elevated high confidence deleterious mutation alternative splicing ddb brca transcript

karaosmanolu

department biology kamil zda faculty science karamanolu mehmetbey university brahim ktem avenue karaman trkiye electronic address oguzhankaraosmanogluwindowslivecom

purpose recurrence main cause hepatocellular carcinoma hcc related death underlying recurrence biology better understood comparative analysis complete set transcript recurrent nonrecurrent hcc study transcriptomic data gse male patient diagnosed either recurrent nonrecurrent hcc reanalyzed identify deregulated pathway somatic mutation fusion transcript alternative splicing event immune context recurrent hcc material method deseq used differential expression analysis mutect somatic mutation analysis arriba starfusion fusion transcript analysis rmats alternative splicing analysis result result revealed myc target gene set hallmarkmyctargetsv hallmarkmyctargetsv significantly enriched recurrent hcc among myc target cbx nop cdk npm mcm mcm pag upregulation significantly associated poor survival somatic mutation analysis demonstrated number high confidence deleterious mutation significantly increased recurrent hcc alternative splicingmediated production nonfunctional ddb oncogenic brca dq discovered recurrent hcc finally cd tcells significantly decreased recurrent hcc conclusion result indicated enrichment myc target gene set one critical factor lead development recurrent hcc addition elevated deleterious mutation number alternative spliced ddb brca isoforms identified prominent contributor increasing genomic instability male patient recurrent hcc

copyright published elsevier bv

doi jadvms

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract eur j oncol nurs oct online ahead print

decisionmaking process riskreducing salpingooophorectomy among korean woman hereditary breast cancer grounded theory study

park sy jin j lee h lim nam ej kim

college nursing daegu catholic university daegu south korea college nursing yonsei university seoul south korea electronic address psycuackr department nursing korea national university transportation jeungpyeong south korea electronic address jhjinutackr moim kim nursing research institute college nursing yonsei university seoul south korea electronic address hkyuleeyuhsac division tumor immunology center gynecologic cancer research institute hospital national cancer center goyang south korea electronic address mclimnccrekr woman cancer clinic division gynecologic oncology department obstetrics gynecology yonsei university college medicine seoul south korea electronic address nahmejyuhsac moim kim nursing research institute college nursing yonsei university seoul south korea electronic address suekimyuhsac

purpose explore decisionmaking process regarding riskreducing salpingooophorectomy rrso among woman hereditary breast cancer korea focus complex interpersonal interaction sociocultural influence method qualitative grounded theory study conducted semistructured indepth interview woman hereditary breast cancer march december theoretical sampling constant comparison utilized data analysis result core concept identified navigating optimal trajectory preserving encompassing four stage conflicting cancerfree health maintaining integrated self recognizing decisionmaker v physician seeking meaningful information evaluating decision result prioritizing value woman conflict influenced time given decide timing brca result complexity surgical choice diverse perspective quality information process often reiterated rrso undertaken conclusion woman hereditary breast cancer grapple conflicting decision preserve integrated self decisionmaking process complex subjective influenced physiciandominated decisionmaking culture subjective meaningful information individual value decisional circumstance supporting woman prioritizing value providing comprehensive information physical emotional relational social impact option crucial oncology nurse play vital role bridging gap physiciandominated decisionmaking patient autonomy facilitating communication supporting patientcentered care

copyright elsevier ltd right reserved

doi jejon

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract nature oct

thirty year since race brca gene

ashworth

doi

abstract clin breast cancer oct doi jclbc online ahead print

disparity hereditary genetic testing patient triple negative breast cancer

gupta jones je smithgraziani

department medicine emory university school medicine atlanta ga department hematology medical oncology winship cancer institute emory university school medicine atlanta ga department hematology medical oncology winship cancer institute emory university school medicine atlanta ga electronic address demetriajoysmithgrazianiemoryedu

triplenegative breast cancer tnbc aggressive subtype breast cancer disproportionately affect younger female nonhispanic black woman hispanic woman woman brca gene mutation hereditary genetic testing particularly important population ass preventative treatment strategy however access genetic testing variable qualitative review performed evaluate barrier genetic testing patient tnbc mutation common breast cancer reviewed along updated guideline management strategy including ability include parp inhibitor treatment strategy barrier genetic testing multifactorial nonhispanic black woman tested le often group disparity even represented limited number nonhispanic black patient tnbc receive riskreducing surgery targeted systemic therapy eliminating barrier genetic testing allow u support guidelinedirected care patient tnbc higher risk genetic mutation

copyright elsevier inc right reserved

doi jclbc

conflict interest statement disclosure author stated conflict interest

abstract case rep oncol sep

successful treatment unresectable brca lmutated basal cell carcinoma invading parietal bone cisplatin fluorouracil case report

yoshidaakai fujimura amagai r kambayashi hashimoto terui h oka k watanabetakahashi yamazaki e ohuchi k asano

department dermatology tohoku university graduate school medicine sendai japan department medical oncology tohoku university hospital sendai japan

introduction basal cell carcinoma bcc common skin cancer rarely metastasizes deeply infiltrate local tissue small number unresectable bcc case make difficult conduct clinical trial resulting delay development effective drug bcc cancer gene panel testing led increasing number new treatment proposal patient solid tumor standard treatment available case presentation described case unresectable brca lmutated bcc invading parietal bone successfully treated cisplatin fluorouracil conclusion present case suggests comprehensive mutation analysis gene panel testing important advanced bcc gene involved hedgehog signaling pathway driver gene

author published karger ag basel

doi pmcid pmc

conflict interest statement author conflicting interest declare

abstract front biosci landmark ed oct doi jfbl

doseresponse effect various concentration clcontaining watersoluble derivative c fullerene selective regulation gene expression human embryonic lung fibroblast helf

kostyuk sv malinovskaya em umriukhin pe mikheeva en ershova e savinova ea kameneva lv troshin pa kraevaya oa rodionov iv kostyuk se salimova ta kutsev si veiko nn

laboratory molecular biology research centre medical genetics moscow russia department physiology im sechenov first moscow state medical university sechenov university moscow russia zhengzhou research institute harbin institute technology zhengzhou henan china federal research center problem chemical physic medicinal chemistry ra chernogolovka russia

background new synthesized watersoluble derivative c fullerene great interest researcher since potentially promising material drug delivery bioimaging biosonding tissue engineering surface functionalization fullerene derivative change chemical physical characteristic increasing solubility suitability different biological system application however change functionalized fullerene modulate cytotoxicity antioxidant property toxic protective effect fullerene derivative cell realized activation inhibition gene protein key signaling pathway cell responsible regulation cellular reactive oxygen specie ro level proliferation apoptosis method dimethylthiazolyl diphenyl tetrazolium bromide mtt assay used ass cell viability flow cytometry analysis applied measure protein level human embryonic lung fibroblast helf cell helf standard stable well described human cell line passaged many time quantitation ro assessed using hdcfhda fluorescence image obtained using microscopy expression bcl ccnd cdkna brca bax nfkb nox nrf tbp reference gene analyzed using realtime polymerase chain reaction pcr result found high low concentration fullerene c derivative five residue potassium salt phenylpropanamidohexanoic f thiophenylacetamidohexanoic f acid chlorine atom attached directly cage cause diametrically opposite activation gene protein key signaling pathway regulating level oxidative stress apoptosis helf high concentration f f genotoxic effect causing nadph oxidase nox expression activation hour fold increase ro synthesis induction increase dna damage break fold oxodg level increase activation nuclear factor kappalightchainenhancer activated b cell nfb background reduced nferelated factor nrf expression low concentration f f produced cytoprotective effect hour reduce oxidative dna damage decrease number doublestrand dna break increase level antiapoptotic protein enhance antioxidant response activating nrf expression nrf gene expression increase fold phosphorylated form nrf protein increase fold conclusion obtained result show low dos studied fullrens may serve perspective dna protector damaging genotoxic factor

author published imr press

doi jfbl indexed medline

abstract sci rep oct

discrepancy somatic brca pathogenic variant two different platform epithelial ovarian fallopian tube peritoneal cancer

kim jh shin jy park sy seo s kang yoo cw park sy lim mc

center gynecologic cancer national cancer center goyang korea department pathology national cancer center korea goyang korea department cancer control policy national cancer center graduate school cancer science policy national cancer center goyang korea center gynecologic cancer national cancer center goyang korea gynlimgmailcom department cancer control policy national cancer center graduate school cancer science policy national cancer center goyang korea gynlimgmailcom division rare refractory cancer research institute national cancer center goyang korea gynlimgmailcom center clinical trial hospital national cancer center goyang korea gynlimgmailcom

somatic brca brca pathogenic variant pvlikely pv lpv next generation sequencing ng important biomarker parp inhibitor use maintenancetargeted therapy discrepancy detection rate brca brca pvlpv identified among ng platform objective study compare somatic brca result two distinct platform using cohort identify cause difference patient epithelial ovarian cancer concurrently underwent tumor ng using two different platform january june included study two platform used inhouse tumor ng illumina nextseq dx sureselectxt library kit datasets genome esp exac clinvar greenplan homologous recombination deficiency hrd test illumina nextseq dx customized twist bioscience library kit datasets cosmic oncokb result somatic mutation brca brca compared two platform patient n exhibited discordant interpretation brca brca two platform eleven patient exhibited negative result inhouse platform positive result eight seven pv brca one pv brca one lpv brca two lpv brca greenplan hrd test three patient positive brca pathogenic variant two pv brca cg c c one lpv brca cg one lpv brca cdelcac inhouse platform negative result greenplan hrd test discordance rate somatic brca brca mutation different platform approximately case strong implication brca pvlpv negative result one genetic test different platform could considered limited case careful interpretation study crossvalidation gene analysis platform needed

author

doi pmcid pmc indexed medline

conflict interest statement author declare competing interest

abstract breast cancer oct online ahead print

clinicopathogenomic analysis pikaktptenaltered luminal metastatic breast cancer japan

tada h miyashita haradashoji n ebata sato motonari yanagaki kon sakamoto ishida

department breast endocrine surgical oncology graduate school medicine tohoku university seiryomachi aobaku sendai miyagi japan hiroshitadaatohokuacjp department breast endocrine surgical oncology graduate school medicine tohoku university seiryomachi aobaku sendai miyagi japan

rapid communication highlight correlation protein kinase b alpha aktphosphatidylinositolbisphosphate kinase catalytic subunit alpha pikca phosphatase tensin homolog pten alteration clinicopathological factor japanese patient metastatic recurrent breast cancer mbc study analyzed patient luminaltype breast cancer underwent cancer gene panel testing result demonstrated akt pathway alteration including pikaktpten occurred case patient akt pathway mutation older p higher rate invasive lobular carcinoma ilc histology p progesterone receptor pgr positivity p bone metastasis p lower rate germline brca p comprehensive genomic profile result demonstrated higher tumor mutational burden tmb lower tumor brca expression patient mutation akt pathway result crucial characterizing candidate akt pathwaytargeted molecular therapy conceptualizing optimal treatment strategy clinical trial registration study observational study therefore registered clinical trial registration

author

doi

abstract medicine baltimore oct e doi md

skin metastasis brca mutated prostate cancer case report brief review literature

jubran basso u milani erbetta e di marco pittarello c cavasin n lai e stragliotto pierantoni f zampiva bimbatti maruzzo

oncology unit istituto oncologico veneto iov irccs padova italy department surgery oncology gastroenterology university padua padua italy oncology unit istituto oncologico veneto iov irccs padova italy department engineering innovation medicine dimi section innovation biomedicine oncology area university verona verona italy

rationale metastatic castrationresistant prostate cancer poor prognosis especially harboring dna damage repair gene mutation nevertheless case pathogenic brca gene mutation parpi demonstrated survival benefit validated treatment nowadays data regarding unusual metastasis drug cutaneous metastasis appear rarely prostate cancer associated worse prognosis moreover consolidated data concerning skin tropism prostate cancer cell neither case brcaassociated cancer patient concern report case patient long history brcamutated metastatic castrationresistant prostate cancer developed skin lesion scalp fifth line systemic therapy olaparib complete radical surgical excision pathology report showed prostate cancer localization diagnosis diagnosis skin metastasis prostate cancer reported outcome patient continued olaparib therapy month excision experienced bone biochemical progression cutaneous progression lesson literature review reported case cutaneous metastasis prostate cancer conducted shed light incidence clinical presentation diagnosis treatment prognosis entity also reviewed published case skin metastasis brcaassociated cancer effort correlate skin involvement parpi treatment brcaness status prognosis

copyright author published wolters kluwer health inc

doi md pmcid pmc indexed medline

conflict interest statement author conflict interest disclose

abstract dna repair amst oct online ahead print

positioning loss parp activity central toxic event brcadeficient cancer

macgilvary n cantor sb

department molecular cell cancer biology university massachusetts chan medical school worcester usa department molecular cell cancer biology university massachusetts chan medical school worcester usa electronic address sharoncantorumassmededu

mechanism polyadpribose polymerase parp inhibitor parpis inflict replication stress andor dna damage potentially numerous parpi toxicity could derive loss catalytic activity andor physical trapping parp onto dna perturbs parp function dna repair dna replication also obstructs compensating pathway combined disruption parp either hereditary breast ovarian cancer gene brca brca brca result synthetic lethality driven development parp inhibitor therapy brcamutant cancer review focus recent finding highlight loss parp catalytic activity rather parpiinduced allosteric trapping central parpi efficacy brca deficient cell however also review finding parptrapping effective strategy genetic deficiency together conclude mechanismofaction parp inhibitor unilateral loss activity enhanced trapping differentially killing depending genetic context therefore effectively targeting cancer cell requires intricate understanding key underlying vulnerability

copyright author published elsevier bv right reserved

doi jdnarep

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract transl lung cancer re oct doi tlcr epub oct

switchsucrose nonfermentable complexdeficient pulmonary neoplasm clinicopathologic characteristic outcome radiotherapy immunotherapy

gu lai yang j zhang j fan x zheng q

department radiation oncology shanghai cancer center fudan university shanghai china department oncology shanghai medical college fudan university shanghai china shanghai clinical research center radiation oncology shanghai china shanghai key laboratory radiation oncology shanghai china xiaogan hospital affiliated wuhan university science technology xiaogan china department pathology fudan university shanghai cancer center shanghai china contributed equally

background switchsucrose nonfermentable swisnf complex multisubunit chromatin remodeler linked aggressive tumor deficient accurate identification swisnf expression status crucial tailoring targeted therapy previous study efficacy immunotherapy swisnfdeficient swisnfd pulmonary tumor primarily focus nonsmall cell lung cancer nsclc limited data modality like radiotherapy study aim analyze clinicopathological characteristic prognostic factor swisnfd pulmonary neoplasm including nsclc undifferentiated tumor evaluate effectiveness radiotherapy immunotherapy providing foundation improved treatment strategy prognostic assessment method patient data swisnfd pulmonary neoplasm collected fudan university shanghai cancer center assessing arida smarca smarca smarcb subunit expression via immunohistochemistry retrospective analysis survival treatment result result study analyzed swisnfd pulmonary neoplasm swisnfd cancer patient january august mostly male smoker showing high malignancy clinicopathologic feature consistent across patient various swisnf subunit deficiency tp common comutated gene followed stk cdkna kras apc egfr key prognostic factor overall survival o distant metastasis radiotherapy immunotherapy immunotherapy improved year o rate p krasmutated patient immunotherapy showed lower year survival rate v p radiotherapy increased year o rate p patient treated immunotherapy benefited radiotherapy median o month v estimable ne p average day radiotherapy immunotherapy conclusion swisnfd pulmonary neoplasm whether multiple single subunit loss exhibit similar clinicopathological characteristic radiotherapy immunotherapy effective treatment patient combination radiotherapy immunotherapy may offer synergistic effect

ame publishing company right reserved

doi tlcr pmcid pmc

conflict interest statement conflict interest author completed icmje uniform disclosure form available httpstlcramegroupscomarticleviewtlcrcoif author conflict interest declare

abstract j ovarian re nov

novel itgb transcript variant sustains ovarian cancer cell survival genomic instability altered ploidy mutant p background

narayanan talreja mali vinay sb bapat sa

national centre cell science pune india savitribai phule pune university pune india institute excellence higher education iehe kaliyasot dam kolar road bhopal india national centre cell science pune india sabapatnccsresin savitribai phule pune university pune india sabapatnccsresin contributed equally

background transcript variant protein isoforms central unique tissue function maintenance homeostasis addition associated aberrant state cancer crosstalk mutated tumor suppressor p may contribute genomic instability chromosomal rearrangement previously identified several novel splice variant ovarian cancer rnasequencing datasets herein aimed elucidate biological effect integrin subunit beta variant termed pitgb method resolution fulllength sequence pitgb rapid amplification cdna end racepcr cell cycle analysis karyotype study performed explore genomic instability rnaseq proteomics analysis used identify differential expression gene result fulllength study revealed unique sequence pitgb differed reported itgb sequence suggesting differential regulation novel transcript p mutant background overexpression pitgb triggered genetic instability reminiscent oncogeneinduced replicative stress extensive abnormal mitoses chromosomal nuclear aberration indicative chromosomal instability leading near wholegenome duplication imposes energy stress cellular resource micronuclei aneuploidy striking feature pitgboverexpressing pmutant cell enhanced p wildtype wt cell rnaseq proteomics analysis suggested p inactivation ovarian cancer provides permissive intracellular molecular niche pitgb mediate effect genomic instability observation pivotal considering highgrade serous ovarian carcinoma hgsc tumor express mutant p resulting aneuploid clone enhanced selfrenewal survival capability disrupt clonal dominance stress yet maintain balance replicative stress prosurvival advantage conclusion pitgboverexpressing clone sustain ovarian tumor cell survival achieve homeostasis formidable opponent therapy

author

doi indexed medline

abstract curr pharm de nov online ahead print

design synthesis molecular docking quinazolines bearing caffeoyl moiety targeting pgkpkmstat signaling pathway human breast cancer

borik rm hussein

department physical science chemistry division college science jazan university po box jazan ksa biotechnology department faculty applied health science technology october university giza egypt

background pgk pkm glycolytic enzyme expression upregulated cancer cell stat transcription factor implicated breast cancer progression chemoresistance researcher worldwide continue explore targeting gene might lead effective antibreast cancer therapy present study aim synthesize quinazolines containing caffeoyl moiety developing innovative anticancer agent human breast cancer cell line mcf method new quinazoline synthesized reacting caffeic acid aminophenylpyrazole carboxylate presence pcl compound reacted nhnhho produce compound cyclocondensation apoptosis necrosis well inhibition activity compound pgk pkm evaluated effect compound level gsh gr sod gpx cat mda bax bcl caspase p vegf level well pgk pkm stat gene expression estimated mcf tumor cell result viability mcf cell reduced incubation compound hour respectively ic value compound gml gml furthermore compound exhibited significant apoptosis necrosis compound ic value compound pgk pkm interval concentration equal mml respectively minute incubation moreover compound revealed strong inhibition pgk pkm ic value equal gml respectively minute incubation result proved incubation compound mcf cell increased level apoptotic protein elevated mda bax caspase p level depleted gsh gr sod gpx cat bcl level downregulated level stat pgk pkm gene expression significantly insilico result proved compound showed stronger estimated binding affinity g kcalmol respectively towards pgk pkm stat protein also compound exhibit strong binding affinity g kcalmol towards pgk pkm stat protein conclusion result show compound induce apoptotic activity blocking pgk pkmstat signaling pathway present investigation open exciting possibility developing innovative new anticancer quinazolines bearing caffeoyl moiety

copyright bentham science publisher query please email epubbenthamsciencenet

doi

abstract sci rep nov

construction validation prognostic signature based microvascular invasion immunerelated gene hepatocellular carcinoma

li h qiao l kong fang h yan z guo r guo w

department hepatobiliary pancreatic surgery first affiliated hospital zhengzhou university east jianshe road zhengzhou henan china thyroid surgery department first affiliated hospital zhengzhou university zhengzhou china henan key laboratory hepatopathy transplantation medicine zhengzhou china henan engineering research center diagnosis treatment hepatobiliary pancreatic surgical disease zhengzhou china department hepatobiliary pancreatic surgery first affiliated hospital zhengzhou university east jianshe road zhengzhou henan china ranguocom national organ transplantation physician training center zhengzhou china ranguocom department hepatobiliary pancreatic surgery first affiliated hospital zhengzhou university east jianshe road zhengzhou henan china guowzcom department henan key laboratory digestive organ transplantation first affiliated hospital zhengzhou university zhengzhou china guowzcom contributed equally

background microvascular invasion mvi independent risk factor poor prognosis hepatocellular carcinoma hcc used guide diagnosis treatment hcc immune system serf integral role incidence progression hcc however molecular biology correlation mvi tumor immunity value combining two parameter predict patient prognosis hcc response treatment remain evaluated result study used univariate cox regression analysis least absolute shrinkage selection operator lasso cox analysis establish mvi immunerelated gene index mirgpi including eight gene demonstrated mirgpi independent risk factor predicting prognosis hcc subsequently research established nomogram model combining pathologic characteristic verified good clinical application value addition study found tp gene higher mutation frequency lower degree immune infiltration highrisk group lowrisk group higher sensitivity immunotherapy sorafenib tace treatment highrisk group higher sensitivity common chemotherapeutic agent finally semac found facilitate proliferation migration invasive ability hcc vitro vivo experiment mechanism may associated activation nfbemt signaling pathway conclusion summary mirgpi signature developed reliable marker prediction prognosis treatment response important prognostic assessment individualized treatment hcc

author

doi indexed medline

abstract sci rep nov

fkbp promotes glycolysis hepatocellular carcinoma progression via phk axis

zeng z xu wang r han x

department nuclear medicine first affiliated hospital zhengzhou university zhengzhou china henan medical key laboratory molecular imaging zhengzhou china department nuclear medicine first affiliated hospital zhengzhou university zhengzhou china wangruihuacom henan medical key laboratory molecular imaging zhengzhou china wangruihuacom department nuclear medicine first affiliated hospital zhengzhou university zhengzhou china xmhanzzueducn henan medical key laboratory molecular imaging zhengzhou china xmhanzzueducn

fkbp member fkbinding protein fkbp family promising target variety disorder including cancer however underlying molecular mechanism potential function hepatocellular carcinoma hcc largely elusive therefore aimed investigate expression status functional implication underlying mechanism fkbp hcc bioinformatics analysis tcga lihc datasets icgc lirijp datasets geo datasets result showed fkbp upregulated hcc tissue also confirmed elevated fkbp clinical hcc sample additionally quantitative rtpcr result revealed fkbp highly expressed five tested hcc cell line also observed correlation elevated fkbp expression poor prognosis hcc patient loss fkbp inhibit proliferation migration hcc cell furthermore found silencing fkbp suppressed glucose uptake lactic acid production ffdg uptake compared control group mechanistically funding indicated fkbp participates glycolysis p mediated hk signaling pathway specially fkbp knockdown promotes expression stability p protein rather affecting transcription level finally rescue experiment revealed simultaneous knockdown fkbp p partially reversed inhibitory effect hk protein level ffdg uptake study elucidates novel role fkbp promoting hcc development glycolysis modulating phk signaling pathway given critical role aerobic glycolysis progression hcc targeting fkbp may offer new therapeutic strategy treating malignancy

author

doi indexed medline

abstract j nippon med sch

current status comprehensive genomic profiling management metastatic castrationresistant prostate cancer study cooperative hospital cancer genomic medicine japan

akatsuka j kimura g takadate hiraoka sahara iwai hasegawa h mikami h obayashi k takeda h endo toyama yamamoto yamada kondo

department urology nippon medical school pathology informatics team riken center advanced intelligence project mathematical intelligence medicine graduate school medicine tohoku university department genetics nippon medical school department digestive surgery nippon medical school

background several effective treatment modality metastatic castrationresistant prostate cancer mcrpc available however unmet clinical need persists mcrpc treatment resistance therapy inevitable study aimed evaluate status comprehensive genomic profiling cgp impact subsequent treatment patient mcrpc hospital method december august assessed patient mcrpc underwent cgp testing nippon medical school hospital testing comprised foundationone cdx patient foundationone liquid cdx patient following procedure outlined japanese urological association result cgp testing successfully conducted patient resulted identification actionable genomic alteration common alteration tp patient twentythree patient druggable gene alteration identified recommended clinical trial four patientproposed healthcare service six insurancecovered drug consequently genotypematched therapy insurancecovered drug administered five patient brca mutation notably none patient underwent clinical prospective trial based patientsuggested medical service conclusion result offer insight realworld application cgp testing patient mcrpc cooperative hospital cancer genomic medicine japan thus urologist require comprehensive understanding current status cgp testing enhance mcrpc management

doi jnmsjnms indexed medline

abstract blood adv nov bloodadvances doi bloodadvances online ahead print

validation revised european leukemianet risk stratification adult patient acute myeloid leukemia

ruhnke l bill zukunft eckardt jn schfer stasik hanoun schroeder fransecky l steffen b krause sw scholl hochhaus sauer kraus schfereckart k kaufmann jost e brmmendorf th schliemann c mikesch jh krug u hnel morgner schaich neubauer repp r niemann seggewissbernhardt r meinhardt kullmer j kaiser u blau w kiani grigoleit gu giagounidis wurm aa altmann h middeke jmm schetelig j mllertidow c stlzel f baldus cd platzbecker u serve h bornhuser thiede c rllig c

department internal medicine university hospital dresden tu dresden dresden germany germany national center tumor disease dresden nctucc medical faculty university hospital carl gustav carus technische universitt dresden dresden germany department hematology university hospital essen university duisburgessen essen germany germany department hematology oncology university hospital schleswigholstein campus kiel kiel germany germany department internal medicine ii university hospital frankfurt frankfurt germany germany uniklinikum erlangen erlangen germany department internal medicine ii hematology medical oncology university hospital jena jena germany germany department internal medicine v university heidelberg heidelberg germany germany uniklinikum wrzburg wrzburg germany klinikum nuernberg nuernberg germany robert bosch hospital stuttgart stuttgart germany department hematology oncology hemostaseology stem cell transplantation university hospital aachen cio abcd aachen rwth aachen aachen germany germany department medicine university hospital mnster mnster germany germany klinikum leverkusen leverkusen germany department internal medicine iii klinikum chemnitz chemnitz germany germany remsmurrklinikum winnenden winnenden germany philippsuniversity marburg germany medizinische klinik stdtisches krankenhaus kiel kiel germany gemeinschaftsklinikum mittelrhein koblenz germany department internal medicine v sozialstiftung bamberg bamberg germany agaplesion diakonieklinikum rotenburg achim germany diako bremen bremen germany st bernward krankenhaus hildesheim germany helios dr horst schmidt klinikum wiesbaden wiesbaden germany klinikum bayreuth bayreuth germany klinikum kassel kassel germany marien hospital dsseldorf germany university hospital leipzig department hematology cell therapy leipzig germany department internal medicine university hospital dresden tu dresden dresden germany agendix gmbh dresden germany germany

european leukemianet eln risk stratification patient aml updated aimed validate prognostic value eln classification eln evaluating newly diagnosed aml patient median age year treated cytarabinebased intensive chemotherapy regimen compared eln classification eln allocating patient favorable intermediate adverse risk category eln risk favorable intermediate adverse patient respectively risk group allocation revised patient patient reclassified eln intermediate eln adverse risk group allocation patient according eln risk category resulted significantly distinct eventfree survival efs relapsefree survival rf overall survival o compared eln reallocation according eln recommendation resulted significantly improved prognostic discrimination o year area curve auc v patient eln favorable risk aml cooccurring mr gene mutation significantly impact outcome within eln adverse risk group observed marked survival difference across mutational group year o rate patient myelodysplasiarelated mr gene mutation tpmutated patient respectively patient harboring mr gene mutation ezh stag zrsrmutated patient showed intermediatelike o patient secondary aml underwent allogeneic hct efs o significantly differed eln risk group prognostic ability eln eln classification similar conclusion eln risk stratification improves prognostic discrimination large cohort intensively treated aml patient given heterogeneous outcome patient mr gene alteration ranging intermediate adverse risk patient suggest reevaluation risk allocation patient

copyright american society hematology

doi bloodadvances

abstract clin epigenetics nov

integrative analysis based atacseq rnaseq reveals novel oncogene prpf hepatocellular carcinoma

bai deng x chen han lin z li z tong w li j wang liu x liu z cui z zhang

department hepatobiliary surgery school medicine tianjin first central hospital nankai university tianjin china tianjin first central hospital clinic institute tianjin medical university tianjin china department hepatobiliary pancreatic surgery tianjin nankai hospital tianjin china school medicine nankai university tianjin china department hepatobiliary surgery school medicine tianjin first central hospital nankai university tianjin china nankaieducn contributed equally

background assay transposase accessible chromatin sequencing atacseq highthroughput sequencing technique detects open chromatin region across genome region critical facilitating transcription factor binding subsequent gene expression herein utilized atacseq identify key molecular target regulating development progression hepatocellular carcinoma hcc elucidate underlying mechanism method first compared chromatin accessibility profile hcc normal tissue subsequently rnaseq data employed identify differentially expressed gene degs integrating atacseq rnaseq data allowed identification transcription factor putative target gene associated differentially accessible region dars finally functional experiment conducted investigate effect identified regulatory factor corresponding target hcc cell proliferation migration result enrichment analysis dars hcc adjacent normal tissue revealed distinct signaling pathway regulatory factor upregulated dars hcc enriched gene related mapk foxo signaling pathway associated transcription factor family like ets ap conversely downregulated dars associated tgf camp p signaling pathway ctcf family integration datasets revealed positive correlation specific dars degs notably prpf emerged gene associated dars hcc functional assay demonstrated ability promote hcc cell proliferation migration best knowledge first report highlighting oncogenic role prpf hcc furthermore znf expression positively correlated prpf chipseq data indicated potential role transcription factor regulating prpf binding promoter region conclusion study provides comprehensive analysis epigenetic landscape hcc encompassing chromatin accessibility transcriptome finding reveal znf promotes proliferation motility hcc cell transcriptional regulation novel oncogene prpf

author

doi sw pmcid pmc indexed medline

conflict interest statement author declare competing interest

abstract colloid surf b biointerfaces oct doi jcolsurfb online ahead print

electrospun nanofibrous scaffold reinforced therapeutic lithiummanganesedoped calcium phosphate advancing skin cancer therapy apoptosis induction

gorgani kermani f sadeghzadeh k vojdani hooshmand foroughi k azari z hosseini sa mollazadeh bideskan ae nazarnezhad

tissue engineering research group terg department anatomy cell biology school medicine mashhad university medical science mashhad iran department anatomy cell biology school medicine mashhad university medical science mashhad iran department material engineering faculty engineering ferdowsi university mashhad fum azadi sq mashhad iran department biological chemical engineering aarhus university aarhus denmark electronic address sarahbceaudk department medical biotechnology nanotechnology faculty medicine mashhad university medical science mashhad iran biological science izn buchman institute molecular life science bmls goetheuniversitt frankfurt main germany department anatomy cell biology school medicine mashhad university medical science mashhad iran applied biomedical research center school medicine mashhad university medical science mashhad iran electronic address ebrahimzadehbamumsacir tissue engineering research group terg department anatomy cell biology school medicine mashhad university medical science mashhad iran metabolic syndrome research center mashhad university medical science mashhad iran electronic address nazarnezhadsmumsacir

current study fabricated potent material incorporating therapeutic element calcium phosphate cps combat cancer involved synthesizing manganese mn lithium lidoped cps loading electrospun nanofibers nfs composed chitosan c polyethylene oxide peo characterized cps exhibited excellent property including particle size nm surface charge mv specific surface area mg electrochemical analysis revealed mn mnlidoped cps promising generating oxygen free radical ho crucial cancer therapy biological evaluation showcased outstanding performance developed material mtt assay revealed cytotoxic effect nanoconstructs melanoma cell line without adverse effect normal l cell h annexin vpi apoptosis assay indicated substantial apoptosis rate cell treated pc obtained data qpcr analysis proapoptotic antiapoptotic gene p bax bcl cell treated different cp nanoparticles np showed significant increase p bax gene expression indicating high level cell apoptosis additionally sample containing mn ion exhibited high reactive oxygen specie ro generation conclusion fabricated nfs scaffold hold promising potential cancer therapy

copyright elsevier bv right reserved

doi jcolsurfb

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract endocr pathol nov online ahead print

satb emergent biomarker anaplastic thyroid carcinoma series comprehensive biomarker molecular study

nkosi crowe altman bj oltvai zn giampoli ej velez mj

department pathology laboratory medicine university rochester medical center rochester ny usa department biomedical genetics university rochester school medicine dentistry rochester ny usa wilmot cancer institute university rochester medical center rochester ny usa department pathology laboratory medicine university rochester medical center rochester ny usa moisesvelezurmcrochesteredu

anaplastic thyroid carcinoma atc rare aggressive thyroid malignancy typically comprised undifferentiated tumor cell various histologic morphology make diagnosis challenging tumor commonly show loss thyroglobulin ttf preservation cytokeratin paired box gene pax expression identification sensitive immunohistochemical stain aid diagnosis atc would beneficial immunohistochemistry ihc special atrich sequencebinding protein satb protein sensitive specific marker expressed colorectal adenocarcinoma bone soft tissue tumor osteoblastic differentiation however satb also expressed sarcomatousundifferentiated neoplasm lacking osteoblastic differentiation using quantitative reverse transcription pcr rtqpcr showed variable expression satb mrna expression atcs evaluate role satb protein expression atc performed pax satb pancytokeratin aeae cam claudin ttf immunostaining case atcs showed retained expression pax satb detected pancytokeratin expressed claudin expressed ttf showed expression case furthermore atcs lacked satb expression retained pax expression tumor without pax expression positive satb differentiated follicular cellderived thyroid cancer n differentiated high grade thyroid carcinoma n poorly differentiated thyroid carcinoma n negative satb immunoreactivity nextgeneration selected case detected commonly identified oncogenic variant including braf ra tp tert promoter overall hereby demonstrate satb ihc may used support diagnosis atc

author

doi

abstract integr biol camb jan zyae

network dynamic investigation omicsdatadriven circadianhypoxia crosstalk logical model gallbladder cancer reveals key therapeutic target combination

singh dwivedi

department bioengineering biotechnology birla institute technology mesra ranchi jharkhand india

recent finding cancer research pointed towards bidirectional interaction circadian hypoxia pathway however little known crosstalk mechanism work aimed investigate crosstalk network level utilizing omics information gallbladder cancer differential gene expression pathway enrichment analysis used selecting crucial gene pathway followed construction logical crosstalk model using ginsim functional circuit identification node perturbation performed significant node combination used investigate temporal behavior network maboss lastly model validated using published vitro experimentation four new positive circuit new axis viz bmal hif nanog responsible stemness identified triple node perturbation viza bmalclock ko e p e hif ko b p e hif ko myc e c hif ko myc e egfr ko model able inhibit cancer growth maintain homeostatic condition work provides architecture drug simulation analysis entrainment circadian rhythm vitro experiment chronotherapyrelated study insight box circadian rhythm hypoxia key dysregulated process fuelsup cancer growth present work developed gallbladder cancer gbc specific boolean model utilizing rnaseq data gbc dataset tissue specific interaction work adequately model bidirectional nature interaction previously illustrated experimental paper showing effect hypoxia dysregulation circadian rhythm influence disruption progression towards metastasis dynamical study model response different perturbation report novel triple node combination targeted efficiently reduce gbc growth network used generalized framework investigate different crosstalk pathway linked cancer progression

author published oxford university press right reserved permission please email journalspermissionsoupcom

doi intbiozyae indexed medline

abstract cell biochem funct dece

protective effect biochanin gamma radiationinduced oxidative stress antioxidant status apoptotic dna repairing molecule swiss albino mouse

yang yang w hu sun wang j shen j ding e

first central clinical school tianjin medical university tianjin china department nuclear medicine second affiliated hospital zhengzhou university zhengzhou china department cardiology fuwai central china cardiovascular hospital zhengzhou china department nuclear medicine tianjin first central hospital tianjin china department ultrasound tianjin first central hospital tianjin china

radiation therapy indispensable medical practice often cause adverse effect healthy tissue necessitating search natural radioprotectors study investigates protective effect biochanin bca gamma radiationinduced oxidative stress dna damage swiss albino mouse gamma radiation potent ionizing source generates reactive oxygen specie ro damage cellular biomolecules including dna antioxidant play crucial role neutralizing ro preventing oxidative damage swiss albino mouse divided control bca control mgkg body weight radiation alone gy radiation bca pretreatment group bca natural isoflavone known antioxidant cytoprotective property administered intraperitoneally radiation exposure irradiation lipid peroxidation level antioxidant enzyme activitieslevel superoxide dismutase catalase glutathione peroxidase reduced glutathione expression level dna repair gene p p gadd apoptotic marker bax bcl caspase cytochromec inflammatory marker nfb analyzed small intestine tissue finding indicate gamma radiation significantly elevated lipid peroxidation level altered antioxidant enzyme activity indicating oxidative stress however bca pretreatment mitigated effect bolstering antioxidant defence reducing radiationinduced oxidative damage additionally bca altered apoptotic marker nfb expression promoting cell survival mechanism molecular level bca pretreatment upregulated key dna repair gene p p gadd crucial repairing radiationinduced dna damage maintaining genomic stability result underscore bca potential radioprotector suggesting efficacy mitigating radiationinduced oxidative stress preserving cellular integrity conclusion bca demonstrates promising radioprotective property attenuating oxidative stress enhancing antioxidant defence modulating apoptotic pathway promoting dna repair mechanism following gamma radiation exposure research necessary elucidate precise mechanism action explore potential therapeutic application radiation oncology environmental radioprotection

john wiley son ltd

doi cbf indexed medline

abstract front oncol oct

potential role nextgeneration sequencing identifying met amplification disclosing resistance mechanism nsclc patient osimertinib resistance

xiao x xu r lu j xin b wang c zhu k zhang h chen x

school physic changchun university science technology changchun china research development department shanghai rightongene biotechnology co ltd shanghai china department respiratory critical care medicine shanghai chest hospital shanghai jiao tong university school medicine shanghai china school life science technology changchun university science technology changchun china

purpose osimertinib one thirdgeneration egfrtyrosine kinase inhibitor tkis designed target egfr tm mutation significantly improves prognosis lung cancer however drug resistance still happens met amplification responsible one main cause fluorescence situ hybridization fish gold standard met amplification detection fundamentally limited observer subjectivity herein assessed value nextgeneration sequencing ng method met amplification detection nonsmall cell lung cancer nsclc well revealed mutation profiling nsclc patient osimertinib resistance provide valuable clue mechanism resistance method total cancer tissue sample nsclc patient time progression following osimertinib submitted ng tissue tested fish simultaneously fish result gold standard enumeration algorithm applied establish optimal model identifying met amplification using gene copy number gcn data result optimal model identifying met amplification constructed based gcn met braf cdk cypa achieved overall agreement fish performed well identifying met amplification except polysomy sensitivity specificity inconsistency ng fish occurred mainly polysomy subtype met gcn could reliably recognized ng moreover frequently mutated gene nsclc patient osimertinib resistance egfr followed tp nrg pikca atm known resistance mechanism including met amplification egfr c lqr tp cdk cdk cdkna braf kras nra pikca mutation also disclosed cohort conclusion ng assay achieve high concordance fish met amplification detection advantage portraying various genetic alteration worthy clinical promotion

copyright xiao xu lu xin wang zhu zhang chen

doi fonc pmcid pmc

conflict interest statement author xx rx bx cw kz employed company shanghai rightongene biotechnology co ltd remaining author declare research conducted absence commercial financial relationship could construed potential conflict interest

abstract funct integr genomics nov

breast cancer genomic analysis reveal gene mutation signaling network

manjunath gk sharma nashier vasanthaiah jha bage mitra goyal p neerathilingam kumar

manipal academy higher education mahe manipal karnataka india institute bioinformatics international technology park whitefield bangalore karnataka india department biotechnology school life science central university rajasthan ajmer rajasthan india manipal academy higher education mahe manipal karnataka india abhishekibioinformaticsorg institute bioinformatics international technology park whitefield bangalore karnataka india abhishekibioinformaticsorg

breast cancer bc commonly diagnosed cancer predominant cause death woman bc complex disorder exploration several type bc omic data highlighting gene perturbation signaling cellular mechanism needed collected mutational data bc sample using cbioportal classified bc gene mutated sample five tier bctieriv subjected pathway proteinprotein network analysis using enrichr string respectively bctieri posse bc gene mutational frequency gene possessing frequency namely pikca tp gata cdh muc next seven bc gene kmtc ttn mapk syne ahnak usha ryr pathway analysis revealed five top bc pathway pikakt tp notch hippo ra pathway found bc panel share seven gene finding show bc arises genetic disruption evident bc signaling protein network

author exclusive licence springerverlag gmbh germany part springer nature

doi sy indexed medline

abstract reprod sci nov online ahead print

effect different concentration prp expression factor involved endometrial receptivity human endometrial cell rif patient compared control

artimani asl s amiri pilehvari yavangi mohammadpour n moravej fg

fertility infertility research center hamadan university medical science hamadan iran artimaniumshaacir anatomy department school medicine hamadan university medical science hamadan iran artimaniumshaacir fertility infertility research center hamadan university medical science hamadan iran anatomy department school medicine hamadan university medical science hamadan iran

plateletrich plasma prp suggested improvement endometrial growth receptivity patient recurrent implantation failure rif aim present study investigate impact different concentration prp expression gene involved endometrial receptivity human endometrial cell rif control thin normal endometrium vitro crosssectional study endometrial biopsy obtained healthy fertile woman woman rif endometrial cell different group rif control endometrial thickness mm mm cultured three different concentration prp expression leukemia inhibitory factor lif cox p estrogen receptor er progesterone receptor pr gene measured using quantitative realtime polymerase chain reaction pcr protein expression level lif cox p evaluated using western blot method wb significant decrease expression proab erb lifb coxb pb gene rif group compared control treatment prp caused significant increase gene expression pr er lifb coxb p rif group moreover protein expression coxb lifb pb increased following treatment prp rif group endometrium thickness mm prp enhances expression lif cox p er pr rif patient thin endometrium may improve endometrium receptivity

author exclusive licence society reproductive investigation

doi sz

abstract inflammation nov online ahead print

multiple machine learning identifies key gene phlda suppressing nafld progression

yang z chen z wang j li zhang h xiang zhang shao z wu p lu lin h tong z liu j dong q

department gastroenterology fifth school clinical medicine zhejiang huzhou central hospital chinese medical university sanhuan north road wuxing district huzhou zhejiang province people republic china qqcom department gastroenterology fifth school clinical medicine zhejiang huzhou central hospital chinese medical university sanhuan north road wuxing district huzhou zhejiang province people republic china huzhou central hospital affiliated central hospital huzhou university huzhou china department biochemistry molecular biology guangdong key laboratory genome instability human disease prevention shenzhen university school medicine shenzhen china department gastroenterology zhongnan hospital wuhan university wuhan china department gastroenterology renmin hospital wuhan university wuhan china huzhou key laboratory precision medicine research translation infectious disease huzhou central hospital affiliated central hospital huzhou university huzhou china contributed equally

nonalcoholic fatty liver disease nafld pose serious global health threat progression mechanism yet fully understood several molecular marker nafld developed recent year lack robust evidence hamper clinical application therefore identifying novel potent biomarkers would directly aid prediction prevention personalized treatment nafld downloaded nafldrelated datasets gene expression omnibus geo differential expression analysis functional analysis initially conducted subsequently weighted gene coexpression network analysis wgcna multiple machine learning strategy employed screen identify key gene diagnostic value assessed using receiver operating characteristic roc analysis explored relationship gene immune cell using transcriptome data singlecell rna sequencing scrnaseq data finally validated finding cell mouse nafld model obtained overlapping differentially expressed gene degs across three nafld datasets enrichment analysis revealed degs associated apoptosis parathyroid hormone synthesis secretion action colorectal cancer p signaling pathway biosynthesis unsaturated fatty acid employing machine learning strategy identified one gene pleckstrin homology like domain family member phlda downregulated nafld showing high diagnostic accuracy cibersort analysis revealed significant association phlda various immune cell singlecell data analysis demonstrated downregulation phlda nafld phlda exhibiting significant negative correlation macrophage furthermore found phlda downregulated vitro hepatic steatosis cell model overexpression phlda significantly reduced lipid accumulation well expression key molecule involved hepatic lipogenesis fatty acid uptake fasn scd cd additionally gene set enrichment analysis gsea pathway enrichment analysis suggested phlda may influence nafld progression pathway cytokine cytokine receptor interaction ecm receptor interaction parkinson disease ribosome pathway conclusion validated mouse model nafld study reveals phlda inhibits progression nafld overexpression phlda significantly reduces lipid accumulation cell markedly decrease expression key molecule involved liver lipogenesis fatty acid uptake therefore phlda may emerge novel potential target future prediction diagnosis targeted prevention nafld

author exclusive licence springer sciencebusiness medium llc part springer nature

doi

abstract npj syst biol appl nov

multibioinformatics revealed potential biomarkers repurposed drug gastric adenocarcinomarelated gastric intestinal metaplasia

andersen gt ianevski resell pojskic n rabben hl geithus kodama hiroyuki kainov grnbech je hayakawa wang tc zhao cm chen

department clinical molecular medicine norwegian university science technology ntnu trondheim norway department surgery st olavs hospital trondheim norway department surgery namsos hospital namsos norway laboratory bioinformatics biostatistics university sarajevo institute genetic engineering biotechnology sarajevo bosnia herzegovina department tumor pathology gifu university graduate school medicine gifu japan department gastroenterology tokyo university hospital tokyo japan department digestive liver disease herbert iring comprehensive cancer center columbia university medical center new york usa department clinical molecular medicine norwegian university science technology ntnu trondheim norway duanchenntnuno

biomarkers associated progression gastric intestinal metaplasia gim gastric adenocarcinoma ga ie garelated gim could provide valuable insight identifying patient increased risk ga aim study utilize multibioinformatics reveal potential biomarkers garelated gim predict potential drug repurposing ga prevention patient multibioinformatics included gene expression matrix gem microarray gene expression mge sctype fully automated ultrafast celltype identification based solely given scrnaseq data ingenuity pathway analysis pagerank centrality go msigdb enrichment cytoscape human protein atlas molecular docking analysis combination immunohistochemistry identify garelated gim paired surgical biopsy collected gimga patient underwent gastrectomy yielding sample biopsy per stomach x patient mge coanalysis performed including scrnaseq immunohistochemistry datasets endoscopic biopsy patient result present study showed potential biomarkers garelated gim including gem individual patient individual gene rbp cd signaling pathway network molecule network signaling pathway key topological node accordingly potential treatment target repurposed drug identified including epidermal growth factor receptor protooncogene tyrosineprotein kinase src paxillin transcription factor jun breast cancer type susceptibility protein cellular tumor antigen p mouse double minute cd

author

doi pmcid pmc indexed medline

conflict interest statement part result included msc thesis geithus httpsntnuopenntnunontnuxmluihandleshowfull phd thesis gt andersen doctoral thesis ntnu otherwise author declare conflict interest

abstract phytochem anal nov online ahead print

study mechanism raspberry rubi fructus treating type diabetes based uplcqexactive orbitrap m network pharmacology experimental validation

wang x zhang x liao q rui x wang r

department pharmacy anhui college traditional chinese medicine wuhu china wuhu modern technology research development center chinese herbal medicine functional food wuhu china college pharmacy dali university dali china

aim aim study analyze chemical composition raspberry using liquid chromatographymass spectrometry lcm technology predict potential effect raspberry treating type diabetes network pharmacology conduct preliminary validation vitro experiment method water cortecs c column mm mm used mobile phase consisted formic acid water mobile phase b consisted formic acid acetonitrile gradient elution performed fullscan mode positive negative ion mode covering mass range mz chemical component raspberry analyzed identified based secondary spectrum database relevant literature disease target related type diabetes searched proteinprotein interaction network analysis well gene ontology go kyoto encyclopedia gene genome kegg pathway enrichment analysis conducted intersecting target active component raspberry disease hepg cell used experimental validation high glucoseinduced insulin resistance model established cck method employed ass effect raspberry cell proliferation western blotting used measure expression protein related agerage signaling pathway result total component identified including organic acid flavonoid phenol alkaloid terpenoids miscellaneous compound stilbene steroid derivative diterpenoid database screening seven active component identified kaempferol epicatechin ellagic acid crocetin stigmasterol fisetin isorhamnetin kegg go result indicated therapeutic effect raspberry type diabetes may related advanced glycation end product age receptor advanced glycation end product rage signaling pathway establishment insulin resistance model hepg cell demonstrated compared control group raspberry treatment group upregulated p protein expression downregulating expression rage akt caspase protein conclusion study preliminarily elucidates therapeutic effect raspberry treating type diabetes may mediated inhibition agerage signaling pathway providing important reference study pharmacological basis clinical application raspberry

john wiley son ltd

doi pca

abstract iscience sep

genetic clinical characteristic genetic tumor syndrome central nervous system cancer implication clinical practice

wang c chen j wang luo n han yin x song chen gong j

department neurosurgery qilu hospital cheeloo college medicine institute brain braininspired science shandong university jinan shandong china shandong key laboratory brain health function remodeling jinan shandong china department oncology affiliated yantai yuhuangding hospital qingdao university yantai shandong china medical department jiangsu simcere diagnostics co ltd nanjing simcere medical laboratory science co ltd state key laboratory neurology oncology drug development nanjing jiangsu china cancer center first affiliated hospital jinzhou medical university jinzhou liaoning china center translational medicine first affiliated hospital jinzhou medical university jinzhou liaoning china

recognizing individual genetic tumor syndrome gts primary central nervous system cns tumor crucial optimizing proper genetic counseling improving therapeutic clinical care retrospectively analyzed gts chinese cns tumor cohort examined molecular characteristic clinical significance diagnostic therapeutic purpose study identified category gts patient cns tumor gene highest germline pathogenic likely pathogenic mutation frequency tp followed msh nf brca top five gts cns tumor showed high genetic heterogeneity gts analysis reclassifies cns tumor nec patient diagnosed gts harbor potential precision oncology therapy target mutation result study deepen understanding cns tumor provide reference direction future design clinical trial expect improve disease entire process management cns tumor

author

doi jisci pmcid pmc

conflict interest statement author declare competing interest

abstract saudi pharm j nov epub oct

salubrious effect proanthocyanidins behavioral phenotype dna repair deficiency btbr mouse model autism

alhusain af mahmoud alhamami hn ebrahim alobid ansari ahmad sf nadeem bakheet sa harisa gi attia sm

department pharmacology toxicology college pharmacy king saud university riyadh saudi arabia department pharmaceutic college pharmacy king saud university riyadh saudi arabia

autism neurodevelopmental disorder distinguished impaired social interaction repetitive behavior global estimate indicate autism affect approximately child condition progressively becoming prevalent time despite noteworthy progress autism research condition remains untreatable serf driving force scientist explore new approach disease management autism linked elevated level oxidative stress disturbance dna repair mechanism may potentially play role comorbidities development current investigation aimed evaluate beneficial effect naturally occurring flavonoid proanthocyanidins behavioral characteristic repair efficacy autistic btbr mouse moreover mechanism responsible effect clarified present finding indicate repeated administration proanthocyanidins effectively reduces altered behavior btbr animal without altering motor function proanthocyanidins decreased oxidative dna strand break accelerated rate dna repair autistic animal evaluated modified comet test addition proanthocyanidins reduced elevated oxidative stress recovered disrupted dna repair mechanism autistic animal decreasing expression gadda parp level enhancing expression ogg p xrcc gene indicates proanthocyanidins significant potential new therapeutic strategy alleviating autistic feature

author

doi jjsps pmcid pmc

conflict interest statement author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract jto clin re rep aug

rearranged transfection rearrangement detection fluorescence situ hybridization compared technique nsclc

mc leer mondet j magnat n mersch giovannini emprou c toffart ac sturm n lantujoul benito

universit grenoble alpes grenoble france service danatomie et cytologie pathologiques ple de biologie et pathologie chu grenoble alpes grenoble france institute advanced bioscience universit grenoble alpes grenoble france timcimag universit grenoblealpes la tronche france clinique hospitalouniversitaire de pneumologie physiologie ple thorax et vaisseaux chu grenoble alpes grenoble france cancer research center lyon centre lon brard lyon france medical affair oncology eli lilly suisse sa dubai united arab emirate

introduction ret rearrangement occur nsclcs since clinically validated ret antibody currently available fluorescence situ hybridization fish often used screening tool identify patient likely benefit rettargeted therapy study performed comprehensive review publication retrearrangement testing performed fish compared method result data method finding electronic search publication using retfish lung cancer compared result obtained grenoble university hospital egfr kras alk rosnegative nsclcs tested ret breakapart fish confirmed rnasequencing rnaseq result publication using retfish analysis pertained patient lung cancer often used positivity threshold six publication compared retfish least one molecular technique least eight sample concordance variable fishpositive case regarding data analyzed sample positive retfish concordance retfish rnaseq retfish positive sample conclusion overall existing literature data suggest retfish testing used rapid screening ret rearrangement nsclc nevertheless using orthogonal technique rnaseq confirm retfishpositive case essential ensuring patient likely benefit rettarget therapy receive treatment

author

doi jjtocrr pmcid pmc

conflict interest statement dr mc leer declared consulting fee janssencilag eli lilly takeda jfr access pfizer payment presentation amgen astrazeneca cancerodigest edimark janssencilag support attending meeting amgen astrazeneca janssencilag pfizer dr toffart declared consulting fee astrazeneca bristolmyers squibb amgen ipsen janssen merck sharp dohme pfizer roche sanofi takeda payment presentation astrazeneca bristolmyers squibb amgen ipsen janssen merck sharp dohme pfizer roche sanofi takeda payment expert testimony astrazeneca bristolmyers squibb amgen ipsen janssen merck sharp dohme pfizer roche sanofi takeda support attending meeting astrazeneca pfizer roche takeda dr benito fulltime employee eli lilly co remaining author declare conflict interest

abstract transl lung cancer re oct doi tlcr epub oct

switchsucrose nonfermentable complexdeficient pulmonary neoplasm clinicopathologic characteristic outcome radiotherapy immunotherapy

gu lai yang j zhang j fan x zheng q

department radiation oncology shanghai cancer center fudan university shanghai china department oncology shanghai medical college fudan university shanghai china shanghai clinical research center radiation oncology shanghai china shanghai key laboratory radiation oncology shanghai china xiaogan hospital affiliated wuhan university science technology xiaogan china department pathology fudan university shanghai cancer center shanghai china contributed equally

background switchsucrose nonfermentable swisnf complex multisubunit chromatin remodeler linked aggressive tumor deficient accurate identification swisnf expression status crucial tailoring targeted therapy previous study efficacy immunotherapy swisnfdeficient swisnfd pulmonary tumor primarily focus nonsmall cell lung cancer nsclc limited data modality like radiotherapy study aim analyze clinicopathological characteristic prognostic factor swisnfd pulmonary neoplasm including nsclc undifferentiated tumor evaluate effectiveness radiotherapy immunotherapy providing foundation improved treatment strategy prognostic assessment method patient data swisnfd pulmonary neoplasm collected fudan university shanghai cancer center assessing arida smarca smarca smarcb subunit expression via immunohistochemistry retrospective analysis survival treatment result result study analyzed swisnfd pulmonary neoplasm swisnfd cancer patient january august mostly male smoker showing high malignancy clinicopathologic feature consistent across patient various swisnf subunit deficiency tp common comutated gene followed stk cdkna kras apc egfr key prognostic factor overall survival o distant metastasis radiotherapy immunotherapy immunotherapy improved year o rate p krasmutated patient immunotherapy showed lower year survival rate v p radiotherapy increased year o rate p patient treated immunotherapy benefited radiotherapy median o month v estimable ne p average day radiotherapy immunotherapy conclusion swisnfd pulmonary neoplasm whether multiple single subunit loss exhibit similar clinicopathological characteristic radiotherapy immunotherapy effective treatment patient combination radiotherapy immunotherapy may offer synergistic effect

ame publishing company right reserved

doi tlcr pmcid pmc

conflict interest statement conflict interest author completed icmje uniform disclosure form available httpstlcramegroupscomarticleviewtlcrcoif author conflict interest declare

abstract heliyon oct e

integrative genomic analysis rnamodificationsingle nucleotide polymorphism associated kidney function

liu x zhu liu x luo x chen c jiang l wu

department nephropathy first affiliated hospital anhui medical university hefei anhui china

introduction increasing evidence suggests rna modification play significant role kidney may ideal target treatment kidney disease however specific mechanism underlying rna modification pathogenesis kidney disease remain unclear genomewide association study gwas identified numerous genetic locus involved kidney function rna modification identification exploration rna modificationrelated singlenucleotide polymorphism rnamsnps associated kidney function help u comprehensively understand underlying mechanism kidney disease identify potential therapeutic target method first examined association rnamsnps egfr second performed expression quantitative trait locus eqtl protein quantitative trait locus pqtl analysis explore function identified rnamsnps finally evaluated causality rnamsnpassociated gene expression circulating protein kidney function using mendelian randomization mr analysis result total rna msnps related atoi mc mg mu identified factor significantly associated egfr total rnamsnps showed ciseqtl effect blood cell whereas rnamsnps showed cispqtl effect plasma rnamsnps exhibited ciseqtl cispqtl effect addition demonstrated causal association rnamsnpassociated gene expression circulating protein level egfr decline identified gene protein reported associated kidney disease cdk sdccag conclusion study reveals association rnamsnps kidney function snp regulate gene expression protein level rna modification eventually leading kidney dysfunction study provides novel insight connect genetic risk kidney disease rna modification suggests potential therapeutic target prevention treatment kidney disease

published elsevier ltd

doi jheliyone pmcid pmc

conflict interest statement author declare following financial interestspersonal relationship may considered potential competing interestsyonggui wu report financial support provided national science foundation china ling jiang report financial support provided national science foundation china anhui provincial department education university research project anhui province translational medicine project cultivation project author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract chem biodivers nov e online ahead print

network pharmacology molecular docking molecular dynamic simulation revealed molecular target potential mechanism nauclea latifolia treatment breast cancer

tepap zemnou c

euromediterranean university fe school engineering biomedtech fesroute meknes morocco fe morocco

breast cancer brca incidence increasing posing significant public health challenge necessitating effective treatment solution nauclea latifolia n latifolia shown anticancer activity multidrugresistant brca cell though mechanism action remains unclear used online database swiss target prediction genecards identify therapeutic target brca active compound n latifolia proteinprotein interaction ppi network constructed using string database cytoscape gene ontology go kyoto encyclopedia gene genome kegg pathway enrichment analysis performed using david database molecular docking gene expression survival analysis core target conducted using autodock gepia database identified intersecting target brca n latifolia compound key target including alb akt esr stat egfr src ptgs gskb mmp ppar target involved cell proliferation death pathway pikakt signaling system metabolic pathway cancer pathway proteoglycans cancer gene expression survival analysis indicated target potential marker brca treatment prognosis study provides insight mechanism action n latifolia brca cell give basis clinician future drug development

wileyvch gmbh

doi cbdv

abstract drug dev re nove

mllt knockdown suppresses proliferation cell mobility human lung adenocarcinoma

shi w zhang zhang l li w chen z xu x

department pulmonary critical care medicine tongji hospital school medicine tongji university shanghai china shanghai lung tumor clinical medical center shanghai chest hospital shanghai jiao tong university shanghai china

lung cancer emerging one frequently encountered malignancy around world carry high morbidity mortality lung adenocarcinoma luad become common subtype lung cancer mllt named af first characterized acute myeloid leukemia downregulate expression several critical gene aim study explore function mllt progression luad related molecular mechanism immunohistochemistry employed ass mllt expression luad tissue quantitative realtime polymerase chain reaction qrtpcr western blot utilized detect mllt expression level lung adenocarcinoma cell line result revealed significant overexpression mllt luad cell line tissue uncovered association mllt expression profile luad tissue metastasis well tnm stage survival analysis showed elevated mllt correlated poorer survival rate also found mllt knockdown repressed luad cell invasion migration proliferation vitro inducing cell cycle arrest apoptosis luad cell moreover knocking mllt inhibited tumor growth vivo specific marker apoptosis cell cycle epithelialmesenchymal transition emt mlltinduced signaling examined western blot demonstrated mllt knockdown inhibited activity egfrmapkerk signaling pathway mllt might novel diagnostic biomarker therapeutic target lung adenocarcinoma

wiley periodical llc

doi ddr indexed medline

abstract diabetes metab syndr obes nov

pathological characteristic ferroptosis kidney tissue type diabetic patient diabetic kidney disease

li zhao liu wang q chen zhou

department endocrinology third hospital hebei medical university shijiazhuang hebei people republic china department nephrology third hospital hebei medical university shijiazhuang hebei people republic china

background diabetes kidney disease dkd common complication diabetes currently considered primary cause endstage renal disease ferroptosis found participate development dkd however ferroptosisrelated marker evaluated human dkd sample study aimed examine ferroptosisrelated pathological alteration dkd sample method study enrolled patient dkd third hospital hebei medical university january december diagnosed dkd nondkd con clinical data patient collected hematoxylineosin staining pasm immunohistochemical staining performed evaluate pathological change expression ferroptosisrelated protein including gpx acsl nrf tfr fth ftl result compared con group patient dkd exhibited significantly elevated serum creatinine level reduced egfr p iron content expression ferroptosisrelated protein acsl significantly increased expression nrf significantly decreased renal tissue patient dkd p difference expression gpx tfr fth ftl two group nrf acsl expression influential factor occurrence dkd exhibited diagnostic value dkd nrf protective factor whereas acsl risk factor conclusion ferroptosispromoting gene profile identified dkd renal sample indicating ferroptosis may participate pathogenesis dkd expression level nrf ascl kidney related severity progression dkd

li et al

doi dmsos pmcid pmc

conflict interest statement author declare conflict interest related study abstract paper presented american diabetes association annual meeting poster presentation poster abstract published poster abstract diabetes supplementlb doi doiorgdblb

abstract biochem genet nov online ahead print

knockdown inhibin beta reversed epithelial growth factor receptor tyrosine kinase inhibitor resistance enhanced therapeutic effect radiotherapy nonsmall cell lung cancer

liu h zhang h yin h wufuer g wang l abuduaini chang x

tumor radiotherapy department ili kazakh autonomous prefecture state friendship hospital yining city xinjiang province china drliuhongfeihotmailcom tumor radiotherapy department ili kazakh autonomous prefecture state friendship hospital yining city xinjiang province china

lung cancer malignant tumor highest mortality rate worldwide nonsmall cell lung cancer nsclc account approximately half lung cancer case inhibin beta inhba ligand transforming growth factorbeta superfamily study aimed analyze function inhba nsclc resistance cell gene expression omnibus cancer genome atlas database used identify differentially expressed gene degs nsclc resistance cell patient degs analyzed gene ontology kyoto encyclopedia gene genome pathway analysis colony formation assay performed determine cell growth cell migration invasion tested transwell assay epithelialmesenchymal transition emtrelated gene analyzed using qrtpcr western blot analysis using bioinformatics tool inhba demonstrated overexpressed nsclc resistant cell patient gefitinib treatment affected nsclc resistant cell additionally inhba silencing xray treatment suppressed growth metastasis nsclc resistant cell moreover combined application inhba silencing xray treatment enhances therapeutic effect moreover emt confirmed occur nsclc resistant cell line inhba silencing xray treatment inhibited emt development study demonstrated inhba silencing ameliorates egfrtki resistance enhances therapeutic effect radiotherapy nsclc

author exclusive licence springer sciencebusiness medium llc part springer nature

doi

abstract chin j integr med nov online ahead print

mechanism asperosaponin vi related egfrmmpaktpik pathway treatment rheumtoid arthritis

luo jf yu liu jx

school basic medicine guizhou university traditional chinese medicine guiyang china sinopakistan center traditional chinese medicine chinapakistan international science technology innovation cooperation base ethnic medicine development hunan province school pharmaceutical science hunan university medicine huaihua city hunan province china liujianxincom

objective explore mechanism action asperosaponin vi avi treatment rheumatoid arthritis ra validate ex vivo experiment using network pharmacology molecular docking method method predicted target avi obtained pharmmaper uniprot swisstarget prediction platform disease target collected online mendelian inheritance man therapeutic target database genecards database intersection target avi ra obtained venny proteinprotein interaction ppi network obtained string database analyzed cytoscape software screened obtain core target cytoscape software used analyze ppi network screen core target based database annotation visualization integrated discovery database gene ontology functional kyoto encyclopedia gene genome pathway enrichment analysis performed cytoscape software used construct diseasepathwaytargetdrug network finally verified molecular docking animal experiment result network pharmacological study showed avi able modulate target target potential treatment ra core pathway aktpik signaling pathway core target epidermal growth factor receptor egfr matrix metalloproteinase mmp molecular docking result showed avi could produce strong binding core target vitro cellular experiment showed avi reduced nitric oxide prostaglandin e tumor necrosis factoralpha tnf interleukin il il level p inhibited cyclooxygenase nitric oxide synthase egfr mmp phosphorylated phosphoinositide kinase ppik phosphorylated serinethreonine kinase pakt protein p result vivo study showed avi improved ra score foot swelling thickness decreased tnf il ppik pakt level ra rat p conclusion avi exerts antiinflammatory antira effect might related egfrmmpaktpik pathway

chinese journal integrated traditional western medicine press springerverlag gmbh germany part springer nature

doi

abstract integr biol camb jan zyae

network dynamic investigation omicsdatadriven circadianhypoxia crosstalk logical model gallbladder cancer reveals key therapeutic target combination

singh dwivedi

department bioengineering biotechnology birla institute technology mesra ranchi jharkhand india

recent finding cancer research pointed towards bidirectional interaction circadian hypoxia pathway however little known crosstalk mechanism work aimed investigate crosstalk network level utilizing omics information gallbladder cancer differential gene expression pathway enrichment analysis used selecting crucial gene pathway followed construction logical crosstalk model using ginsim functional circuit identification node perturbation performed significant node combination used investigate temporal behavior network maboss lastly model validated using published vitro experimentation four new positive circuit new axis viz bmal hif nanog responsible stemness identified triple node perturbation viza bmalclock ko e p e hif ko b p e hif ko myc e c hif ko myc e egfr ko model able inhibit cancer growth maintain homeostatic condition work provides architecture drug simulation analysis entrainment circadian rhythm vitro experiment chronotherapyrelated study insight box circadian rhythm hypoxia key dysregulated process fuelsup cancer growth present work developed gallbladder cancer gbc specific boolean model utilizing rnaseq data gbc dataset tissue specific interaction work adequately model bidirectional nature interaction previously illustrated experimental paper showing effect hypoxia dysregulation circadian rhythm influence disruption progression towards metastasis dynamical study model response different perturbation report novel triple node combination targeted efficiently reduce gbc growth network used generalized framework investigate different crosstalk pathway linked cancer progression

author published oxford university press right reserved permission please email journalspermissionsoupcom

doi intbiozyae indexed medline

abstract front oncol oct

potential role nextgeneration sequencing identifying met amplification disclosing resistance mechanism nsclc patient osimertinib resistance

xiao x xu r lu j xin b wang c zhu k zhang h chen x

school physic changchun university science technology changchun china research development department shanghai rightongene biotechnology co ltd shanghai china department respiratory critical care medicine shanghai chest hospital shanghai jiao tong university school medicine shanghai china school life science technology changchun university science technology changchun china

purpose osimertinib one thirdgeneration egfrtyrosine kinase inhibitor tkis designed target egfr tm mutation significantly improves prognosis lung cancer however drug resistance still happens met amplification responsible one main cause fluorescence situ hybridization fish gold standard met amplification detection fundamentally limited observer subjectivity herein assessed value nextgeneration sequencing ng method met amplification detection nonsmall cell lung cancer nsclc well revealed mutation profiling nsclc patient osimertinib resistance provide valuable clue mechanism resistance method total cancer tissue sample nsclc patient time progression following osimertinib submitted ng tissue tested fish simultaneously fish result gold standard enumeration algorithm applied establish optimal model identifying met amplification using gene copy number gcn data result optimal model identifying met amplification constructed based gcn met braf cdk cypa achieved overall agreement fish performed well identifying met amplification except polysomy sensitivity specificity inconsistency ng fish occurred mainly polysomy subtype met gcn could reliably recognized ng moreover frequently mutated gene nsclc patient osimertinib resistance egfr followed tp nrg pikca atm known resistance mechanism including met amplification egfr c lqr tp cdk cdk cdkna braf kras nra pikca mutation also disclosed cohort conclusion ng assay achieve high concordance fish met amplification detection advantage portraying various genetic alteration worthy clinical promotion

copyright xiao xu lu xin wang zhu zhang chen

doi fonc pmcid pmc

conflict interest statement author xx rx bx cw kz employed company shanghai rightongene biotechnology co ltd remaining author declare research conducted absence commercial financial relationship could construed potential conflict interest

abstract front oncol oct

comprehensive liquid biopsy analysis monitoring nsclc patient secondline osimertinib treatment

ntzifa marras kallergi g kotsakis georgoulias v lianidou e

analysis circulating tumor cell lab lab analytical chemistry department chemistry national kapodistrian university athens athens greece laboratory biochemistrymetastatic signaling section genetics cell biology development department biology university patras patras greece department medical oncology general university hospital larissa larissa greece first department medical oncology metropolitan general hospital athens cholargos greece

background heterogeneous complex genetic landscape nsclc impact clinical outcome patient eventually develop resistance osimertinib liquid biopsy lb analysis minimally invasive approach key step efficiently identify resistance mechanism adjust proper subsequent treatment material method present study combined plasmacfdna ctc analysis nsclc patient sample collected treatment progression disease pd detected molecular alteration dna mutation egfr pikca kras gc braf dna methylation rassfa brms foxa slfn shisa rar wif rassf apc gene expression ck ck ck axl twist pdl pim vimentin aldh bm chromosomal level met amplification possible resistance mechanism druggable target also studied expression pdl single ctc using immunofluorescence result case tm resistance egfr mutation detected baseline ctc corresponding plasma cfdna pikca mutation detected plasmacfdna corresponding ctc kras gc braf mutation detected sample analyzed met amplification detected ctc two patient treatment whereas amplification detected ctc three patient baseline one patient pd dna methylation analysis revealed low concordance ctc cfdna indicating complementary information obtained parallel lb analysis result gene expression analysis indicated high rate vimentinpositive ctc detected time point osimertinib moreover increased number nsclc patient pd harboring ctc positive pdl axl pim expression detected ctc treatment suggesting new possible therapeutic strategy discussion result reveal comprehensive liquid biopsy analysis efficiently represent heterogeneous molecular landscape provide prominent information subsequent treatment nsclc patient pd since druggable molecular alteration detected ctc

copyright ntzifa marras kallergi kotsakis georgoulias lianidou

doi fonc pmcid pmc

conflict interest statement author declare research conducted absence commercial financial relationship could construed potential conflict interest author declared editorial board member frontier time submission impact peer review process final decision

abstract j inflamm re oct

mechanism cyperus rotundus ameliorates osteoarthritis work based network pharmacology

du md ky fan sq li jy liu jf lei zq qin g

department osteoarthrosis xingan jieshou orthopedics hospital guilin people republic china department orthopaedic trauma hand surgery first affiliated hospital guangxi medical university nanning people republic china department osteoarthrosis first affiliated hospital guangxi traditional chinese medical university nanning people republic china contributed equally

background cyperus rotundus cr widely used traditional chinese medicine prevent treat variety disease however function mechanism action osteoarthritis oa elucidated comprehensive strategy combining network pharmacology molecular docking molecular dynamic simulation vitro experiment used address issue method bioactive ingredient cr screened tcmsp database potential target ingredient obtained swiss target prediction database gene oa pathogenesis collected genecards omim disgenet database gene ontology go analysis kyoto encyclopedia gene genome kegg enrichment analysis performed using david database string database cytoscape software used construct componenttargetpathway network predict core target affected cr binding affinity bioactive component core target evaluated molecular docking molecular dynamic simulation therapeutic activity kaempferol chondrocytes inflammatory condition verified vitro experiment result fifteen cr bioactive ingredient obtained targeting oarelated gene series biological process cell component molecular function pathway predicted modulated cr component core target cr oa treatment akt serinethreonine kinase akt interleukin beta ilb src protooncogene nonreceptor tyrosine kinase src bcl apoptosis regulator bcl signal transducer activator transcription stat epidermal growth factor receptor egfr hypoxiainducible factor subunit alpha hifa matrix metallopeptidase mmp estrogen receptor esr pparg orthologs vertebrate pparg main bioactive ingredient cr showed good binding affinity target addition kaempferol one cr bioactive component weakens effect il viability apoptosis inflammation chondrocytes conclusion theoretically cr great potential ameliorate symptom progression oa via multiple component multiple target multiple downstream pathway

du et al

doi jirs pmcid pmc

conflict interest statement author declare competing interest

abstract oncol lett oct jan

sh domainbinding glutamic acidrich proteinlike associated hyperglycemia poor outcome epsteinbarr virusnegative gastric carcinoma

li h zheng l zhang x yu x zhong g chen x chen x chen l

shengli clinical medical college fujian medical university fuzhou fujian pr china department pathology fuzhou university affiliated provincial hospital fuzhou fujian pr china department pathology fujian provincial hospital fuzhou fujian pr china nursing department fujian provincial hospital fuzhou fujian pr china department pathology second affiliated hospital fujian traditional chinese medical university fuzhou fujian pr china department pathology first affiliated hospital fujian medical university fuzhou fujian pr china

sh domainbinding glutamic acidrich proteinlike shbgrl involved several human cancer however relationship gastric cancer gc remains elusive multiple online bioinformatic tool used evaluate messenger mrna expression level shbgrl gc using data cancer genome atlas gene expression omnibus database reverse transcriptionquantitative pcr tissue microarraybased immunohistochemistry performed ass shbgrl expression relation clinicopathological parameter outcome patient gc significant differentially expressed gene degs shbgrl enriched visualized furthermore association expression shbgrl infiltration immune cell explored shbgrl exhibited aberrant expression tumor tissue compared adjacent normal tissue mrna protein expression level especially epsteinbarr virusnegative gc ebvngc higher shbgrl expression significantly associated increasing tumornodemetastasis staging tumor budding perineural invasion egfr expression notably higher preoperative blood glucose concentration clinical specimen multivariate analysis revealed higher shbgrl expression independent adverse prognostic factor overall survival patient ebvngc hazard ratio p furthermore stratified analysis revealed shbgrl phenotype could help refine prognosis patient cindex nomogram combining shbgrl clinicopathological parameter indicated good model clinical followup decision gene functional enrichment analysis also revealed degs shbgrl mainly enriched regulating atp metabolism atp synthesis oxidative phosphorylation electron transport chain gc moreover higher shbgrl expression significantly positively correlated infiltrating macrophage gc conclusion shbgrl upregulated gc particularly ebvngc higher shbgrl expression closely associated hyperglycemia poor outcome patient ebvngc suggesting potential biomarker prognostic predictor

copyright li et al

doi ol pmcid pmc

conflict interest statement author declare competing interest

abstract zhongguo fei ai za zhi sep doi jissn

potential value neoadjuvant immunochemotherapy patient driver genepositive nonsmall cell lung cancer

article chinese abstract available chinese publisher

wei z zhou pu x yan x

department thoracic oncology peking university people hospital beijing china second department thoracic oncology affiliated cancer hospital xiangya school medicine central south universityhunan cancer hospital changsha china

background proportion patient carrying driver gene mutation notably high among individual nonsmall cell lung cancer nsclc china however current neoadjuvant treatment strategy patient lack evident benefit study aim investigate efficacy adverse reaction neoadjuvant immunochemotherapy patient driver genepositive nsclc thereby exploring potential therapeutic value method total patient two center retrospectively collected compare efficacy adverse reaction among driver genepositive nsclc patient different treatment explore response neoadjuvant immunochemotherapy among different egfrsensitive subtypes result total patient two center included study among patient peking university people hospital pkuph received neoadjuvant immunotherapy showing partial response imaging major pathological response mpr rate neoadjuvant immunochemotherapy pathological complete response pcr observed group significant difference noted adverse event impact surgical difficulty among different treatment additionally patient hunan cancer hospital hnca included analyze difference efficiency among egfrsensitive subtypes various neoadjuvant strategy significant radiological response difference observed neoadjuvant immunotherapy targeted therapy however patient lr mutation exhibited mpr pcr receiving immunotherapy surpassing targeted therapy outcome significant difference found among del patient conclusion premise exacerbating adverse effect neoadjuvant immunochemotherapy achieved superior rate mpr pcr longterm survival comparable targeted therapy

publisher nonsmall cell lung cancer nsclcnsclc peking university people hospital pkuphnsclchunan cancer hospital hncaepidermal growth factor receptor egfregfr pkuphmajor pathological response mprpathological complete response pcrhncaegfrlrmprpcrdel mprpcr

doi jissn pmcid pmc indexed medline

conflict interest statement competing interest author declare competing interest

abstract sci prog octdec

predictive model computed tomography clinical feature egfr gene mutation lung adenocarcinoma

yao zhang n lu c liu l fu gui

school public health hainan medical university haikou china department rehabilitation haikou hospital traditional chinese medicine haikou china department oncology first affiliated hospital hainan medical university haikou china

purpose study aim develop predictive model epidermal growth factor receptor egfr mutation lung adenocarcinoma integrating computed tomography ct imaging feature clinical characteristic method retrospective analysis conducted using electronic medical record patient diagnosed lung adenocarcinoma january december approval institutional review board feature selected using lasso regression predictive model built using logistic regression support vector machine random forest method individual model created clinical feature ct imaging feature combined model predict egfr mutation result training set revealed alcohol consumption intrapulmonary metastasis pleural effusion statistically significant distinguishing wildtype mutation group p testing set hilar mediastinal lymphadenopathy showed statistical significance p combined model outperformed individual clinical ct imaging feature model testing set logistic regression model achieved highest auc sensitivity specificity accuracy respectively nomogram analysis identified lobulation important feature predicted probability decision curve analysis showed ct imaging feature model provided higher net benefit compared clinical feature model combined model conclusion summary combined model outperformed individual feature model testing set ct imaging feature model demonstrated greatest clinical net benefit lobulation identified important predictor egfr mutation lung adenocarcinoma

doi pmcid pmc indexed medline

conflict interest statement declaration conflicting intereststhe author declared potential conflict interest respect research authorship andor publication article

abstract sci rep nov

mfapl predicts tumor microenvironment status molecular subtypes clinical benefit patient bladder cancer

xie g qi yao feng zhou w

department urology hunan aerospace hospital changsha china xiangya school medicine central south university changsha china department urology third xiangya hospital central south university changsha china qqcom department urology national clinical research center geriatric disorder xiangya hospital central south university changsha china zhouwmcom national clinical research center geriatric disorder xiangya hospital changsha china zhouwmcom

bladder cancer blca ranking tenth prevalent malignancy globally imposes substantial public health socioeconomic challenge despite ongoing effort urologist identify novel molecular subtypes treatment paradigm intrinsic heterogeneity blca continues obstruct efficacy current diagnostic therapeutic evaluation leaving gap comprehensive management blca necessitates indepth investigation blca tumor microenvironment tme identify pivotal molecule like mfapl research concentrated mfapl commencing pancancer analysis immune profile discovered mfapl exhibit significant negative correlation numerous immune component marker blca trend observed cancer type within tcgablca cohort patient classified highmfapl lowmfapl group according mfapl transcript level exploration blca tme delved immune infiltration molecular subtype pattern treatment preference within mfapl group high mfapl expression linked favorable prognosis luminal subtypes low immune infiltration inversely associated various immune molecule characteristic additionally high mfapl expressors exhibited diminished immune checkpoint level suggesting enhanced immunotherapy tolerance sensitivity oncogenic pathway targeting conversely low mfapl expression correlated poor outcome basal subtypes increased immune infiltration heightened gene mutation rate alongside sensitivity radiotherapy egfrtargeted treatment immunotherapy hence mfapl emerges critical yet underexplored gene blca offering insight immune status within tme aiding molecular subtyping therapeutic decisionmaking

author

doi sw pmcid pmc indexed medline

conflict interest statement author declare competing interest

abstract biorxiv preprint oct doi

expressiondriven genetic dependency reveals target precision medicine

elmas layden hm elli jd bartlett ln zhao x kawabataiwakawa r obinata h hiebert sw huang kl

cancer cell heterogeneous harboring distinct molecular aberration dependent different gene survival proliferation successful targeted therapy developed based driver dna mutation many patient tumor lack druggable mutation limited treatment option hypothesize new precision oncology target may identified expressiondriven dependency whereby cancer cell high expression targeted gene vulnerable knockout gene introduce bayesian approach beacon identify target jointly analyzing global transcriptomic proteomic profile genetic dependency data cancer cell line across tissue lineage beacon identifies known druggable gene eg bcl erbb egfr esr myc revealing new target confirmed mrna proteinexpression driven dependency notably identified gene show overall fold enrichment approved drug target enrich druggable oncology target fold experimentally validate depletion grhl tp pax effectively reduce tumor cell growth survival dependent cell overall present catalog expressdriven dependency target resource identifying novel therapeutic target precision oncology

doi pmcid pmc

abstract ac appl bio mater oct online ahead print

diblock copolymer targeted lipid nanoparticles nextgeneration nucleic acid delivery system produced confined impinging jet mixer

kim b subraveti sn liu jx nayagam sk merghoub caggiano nj amelemah df jiang bizmark n conway jm tsourkas prudhomme rk

department chemical biological engineering princeton university princeton new jersey united state department biomedical engineering columbia university new york new york united state department bioengineering university pennsylvania philadelphia pennsylvania united state

despite recent advance clinical demonstration lipid nanoparticles lnps therapeutic prophylactic application extrahepatic delivery nucleic acid remains significant challenge field limitation arises rapid desorption lipidpeg bloodstream clearance liver hinders extrahepatic delivery response explore substitution lipidpeg biodegradable block copolymer bcps specifically polycaprolactoneblockpolyethylene glycol pclbpeg bcps offer strong anchoring large macromolecule potentially enhancing cellspecific targeting develop optimize bcpstabilized lnps bcplnps employed design experiment doe approach systematic exploration identified optimal formulation bcplnps achieving desirable physicochemical property encapsulation efficiency notably bcplnps exhibit surprising trend transfection efficiency certain formulation showing fold increase transfection hela cell maintaining minimal cytotoxicity lipid composition optimized pclbpeg lnp transfection different composition optimized peglipid lnp transfection furthermore study confirms versatility bcplnps encapsulating delivering mrna pdna demonstrating cargoagnostic nature lastly showcased targeted bcplnps using cetuximabconjugated formulation targeted lnps show significant promise delivering cargo specific egfroverexpressing cell cell time higher transfection compared nontargeted lnps finding underscore potential bcplnps targeted gene therapy especially challenging scenario tumor targeting overall study establishes viability bcplnps versatile efficient targeted delivery platform nucleic acid opening avenue advanced therapeutic application

doi acsabmc

abstract dokl biochem biophys oct online ahead print

effect overexpression specific subunit sayp bap chromatin remodeling complex drosophila melanogaster

chmykhalo vk shidlovskii yv lebedeva la schedl p giordano e

institute gene biology russian academy science laboratory gene expression regulation development moscow russia vkchmykhaloicloudcom institute gene biology russian academy science laboratory gene expression regulation development moscow russia princeton university princeton usa universit di napoli federico ii naples italy

phenotypic manifestation increased expression bap ey sayp gene melanogaster analyzed using wing disc model show moderate coexpression bap ey gene wing disc lead abnormality wing veining probably caused suppression egfrrasmapk signaling pathway strong induction coexpression gene wing disc lead complete suppression wing development adult ubiquitous coexpression bap ey lethal st instar larval stage lead formation melanotic tumor phenotype observed exclusively bap ey coexpressed evidence suggests robust synergistic effect combined action gene manifested hyperactivity cell proliferation differentiation

pleiades publishing ltd

doi sx

abstract nat chem biol oct online ahead print

multiplex singlecell rnaseq pharmacotranscriptomics pipeline drug discovery

dini barker h piki e sharma raivola j murumgi ungureanu

disease network unit faculty biochemistry molecular medicine university oulu oulu finland tampere university hospital faculty medicine health technology tampere university tampere finland applied tumor genomics research program unit faculty medicine university helsinki helsinki finland institute molecular medicine finland fimm helsinki institute life science hilife university helsinki helsinki finland disease network unit faculty biochemistry molecular medicine university oulu oulu finland danielaungureanuoulufi applied tumor genomics research program unit faculty medicine university helsinki helsinki finland danielaungureanuoulufi

generegulatory dynamic governing drug response cancer yet fully understood report pipeline capable producing highthroughput pharmacotranscriptomic profiling livecell barcoding using antibodyoligonucleotide conjugate pipeline combine drug screening plex singlecell rna sequencing show potential approach exploring heterogeneous transcriptional landscape primary highgrade serous ovarian cancer hgsoc cell treatment drug distinct class mechanism action subset phosphatidylinositol oh kinase pik protein kinase b akt mammalian target rapamycin mtor inhibitor induced activation receptor tyrosine kinase epithelial growth factor receptor egfr mediated upregulation caveolin cav drug resistance feedback loop could mitigated synergistic action agent targeting pikaktmtor egfr hgsoc cav egfr expression using workflow could enable personalized testing patientderived tumor sample singlecell resolution

author

doi

abstract front immunol oct

mechanism underlying bcell developmental dysfunction kawasaki disease based singlecell transcriptomic sequencing

lin q wang z ding g li g chen l qiu q song liu w jiang x huang shen l xiao xie l

department cardiology shanghai childrens hospital school medicine shanghai jiao tong university shanghai china shanghai institute nutrition health university chinese academy science chinese academy science shanghai china institute digital health international human phenome institute shanghai shanghai china daozhi precision medicine technology co ltd shanghai china institute pediatric infection immunity critical care medicine school medicine shanghai jiao tong university shanghai china department pediatrics jinshan hospital fudan university shanghai china contributed equally

background kawasaki disease kd acute systemic vasculitis lead acquired heart disease child mostly developed country previous research showed b cell kd patient underwent profound change cell number type intravenous immunoglobulin ivig therapy method performed singlecell rnasequencing peripheral blood mononuclear cell pbmcs three febrile patient three kd patient investigate possible mechanism underlying b cell developmental dysfunction kd pseudotime analysis employed study developmental trajectory pbmcs febrile control kd patient result overall singlecell expression profile show biological process immunity b cell activation pathway related biological entity repressed kd patient ivig treatment compared febrile patient kd patient ivig treatment differentially expressed gene analysis demonstrate b cell signaling pathway downregulated b cell plasma blast cell kd patient treatment cell cycle gene myc gene upregulated dendritic cell dc hematopoietic stem progenitor cell hspcs kd patient treatment biological process immune response upregulated hspcs kd patient treatment dataset biological process inflammatory response upregulated hspcs kd patient treatment gse dataset singlecell trajectory analysis demonstrate kd patient treatment shortened developmental path b cell cell failed differentiate separate lineage hspd hspe gene show elevated expression level early cell development stage kd patient treatment accompanied repression myc spi mta ubec gene analysis b cell kd patient treatment show b cell arrested transitional state ill developmental path compared febrile patient kd patient treatment conclusion result indicate immune premature hspcs accompanied abnormal expression dynamic cell cycle spi gene mechanism underlying b cell developmental dysfunction kd patient

copyright lin wang ding li chen qiu song liu jiang huang shen xiao xie

doi fimmu pmcid pmc indexed medline

conflict interest statement author gl employed company daozhi precision medicine technology shanghai co ltd remaining author declare research conducted absence commercial financial relationship could construed potential conflict interest

abstract comput biol med nov online ahead print

silico exploration phytochemical inhibitor acute myeloid leukemia targeting lina gene cheminformatics study

hassan hassanein se elabsawy ea

department bioinformatics genetic engineering biotechnology research institute gebri university sadat city sadat egypt electronic address amrhassannanotechnologygmailcom agricultural genetic engineering research institute ageri agriculture research center arc giza egypt bioinformatics program school biotechnology nile university giza egypt department bioinformatics genetic engineering biotechnology research institute gebri university sadat city sadat egypt

background recent discovery illustrated lina oncogene various cancer particularly acute myeloid leukemia aml upregulation lina actively contribute tumorigenesis migration process multiple organ hence inhibition lina achieved applying phytochemical herbal targeting lina protein using computeraided drug design caad approach method study comprehensively applied several bioinformatics tool including gene ontology gene enrichment analysis proteinprotein interaction ppi determine biological pathway functional gene ontology biological pathway furthermore investigated list phytochemical herb candidate drug applying computation technique involving molecular docking density functional theory dft molecular dynamic simulation md pharmacokinetic physiochemical property applying swissadme pkcsm molsoft llc webservers result lina gene related two significant enrichment pathway including proteoglycans cancer pluripotency stem cell interaction different gene mapk myc mtor pikca interestingly limonin glycyrrhetic acid baicalein highest binding energy score kcalmol respectively dft study revealed baicalein higher reactivity limonin glycyrrhetic due small energy gap lumo humo molecular dynamic simulation exhibited baicalein complex lina protein stable complex simulation time due low fluctuation simulation period compared complex indicated baicalein fitting docking combining protein cave largest number hbonds available docking simulation process furthermore druglikeness admet profile revealed activity limonin baicalein glycyrrhizic acid posse significant inhibiting lina protein conclusion study elucidated baicalein glycyrrhizic limonin may applied potential candidate targeting lina active oncogene acute myeloid leukemia

copyright elsevier ltd right reserved

doi jcompbiomed

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract cancer med nove

isobutyric acid promotes immune evasion colorectal cancer via increased pdl expression

lin q wang h chen w wei x chen j deng wei c lai h mo x tang w luo

department gastrointestinal surgery guangxi medical university cancer hospital guangxi medical university nanning guangxi pr china guangxi key laboratory basic translational research colorectal cancer nanning guangxi pr china department ultrasound guangxi medical university cancer hospital guangxi medical university nanning guangxi pr china

introduction isobutyric acid iba shortchain fatty acid unequivocally demonstrated exert significant influence progression colorectal cancer crc nevertheless comprehensive understanding intricate regulatory mechanism remains elusive method employing advanced technique western blot rtqpcr flow cytometry systematically investigated impact iba expression pdl crc cell concurrently employing rna silencing technology smallmolecule inhibitor delved molecular intricacy underlying regulatory axis iba involving rockcmycpdl furthermore flow cytometry analysis examined alteration tumor immune microenvironment following antipdl antibody therapy murine tumor model treated iba result elevated level iba found robustly activate pdl expression crc cell vitro vivo concomitantly reshaping tumor immune microenvironment subsequent mechanistic investigation unveiled iba interaction activation rock promotes activation cmyc thereby enhancing transcription pdl silencing rock application rock inhibitor effectively reversed regulatory effect iba pdl additionally iba inhibited activity infiltrating cd cell resulting diminished antitumor immunity attenuating sensitivity antipdl therapy conclusion study elucidates novel mechanism iba inhibits sensitivity crc antipdl antibody therapy emphasizing iba downstream pathway potential therapeutic target immune therapy resistance mechanism finding provide novel theoretical foundation overcoming immune therapy resistance

author cancer medicine published john wiley son ltd

doi cam indexed medline

abstract mol carcinog nov online ahead print

nek promotes escc malignant progression inhibiting cellular senescence via foxmcmycp signaling pathway

li j wang wei xu dai zhang l tian z zhao l lv h

department thoracic surgery fourth hospital hebei medical university shijiazhuang hebei china research center fourth hospital hebei medical university shijiazhuang hebei china key laboratory tumor gene diagnosis prevention therapy hebei province fourth hospital hebei medical university shijiazhuang hebei china department geriatric third hospital hebei medical university shijiazhuang hebei china

never mitosis gene nimarelated kinase nek crucial serinethreonine kinase involved process cell mitosis however precise relationship nek esophageal squamous cell carcinoma escc remains inadequately understood nek expression escc tissue assessed bioinformatics analysis reverse transcriptionquantitative pcr rtqpcr immunohistochemistry revealing correlation escc patient prognosis cultured escc cell human normal esophageal epithelial cell heec used investigate effect nek knockdown development progression escc integrated confluence algorithm colony formation woundhealing transwell escc xenograft tumor model vitro vivo escc tissue nek found significantly upregulated expression correlated poor prognosis escc patient nek may facilitate escc development regulating cell proliferation migration invasion additionally result vivo experiment suggested nek knockdown inhibit tumor growth moreover forkhead box foxm identified potential downstream target nek regulation escc overexpression reversing effect nek knockdown escc mechanistic study also indicated nek may promote malignant progression escc inhibiting cellular senescence activation foxmcmycp signaling pathway may provide novel perspective management escc

wiley periodical llc

doi mc

abstract anim cell syst seoul nov doi

ap promotes proliferation esophageal squamous cell carcinoma cell histone lactylation nfb pdependent transcription activation mettlmediated mrna stability cmyc

fu c jiang w wang c song sj tao h zhang xg li wt jin x yu bb hao jj sun wj bai j shi zz

medical school kunming university science technology kunming people republic china department thoracic surgery affiliated hospital kunming university science technology first people hospital yunnan province kunming people republic china department anus intestine surgery kunming municipal hospital traditional chinese medicine kunming people republic china state key laboratory molecular oncology center cancer precision medicine national clinical research center cancercancer hospital national cancer center chinese academy medical science cam peking union medical college pumc beijing people republic china nephrology division puer people hospital puer people republic china

esophageal squamous cell carcinoma escc aggressive malignant neoplasm role long noncoding rna lncrna ap cancer including escc absolutely unclear gepia database applied identify differentially expressed prognosisassociated gene esophageal cancer esca cck colony formation western blot qrtpcr method harnessed investigate role mechanism ap esophageal carcinogenesis analyzing tcga data gepia database two lncrnas selected ap overexpressed positively associated unfavorable outcome escc patient linc underexpressed negatively linked poor prognosis knockdown ap suppressed proliferation colony formation escc cell importantly silence ap downregulated cmyc mechanically knockdown ap reduced mettl expression modification cmyc mrna mettl positively regulated cmyc furthermore knockdown ap diminished histone lactylation nfb p expression protein lactylation inhibitor dg deoxydglucose oxamate nfb inhibitor jsh also lessened cmyc expression consequently finding suggested ap promoted proliferation esophageal squamous cell carcinoma cell histone lactylation nfb pdependent transcription activation mettlmediated mrna stability cmyc

author published informa uk limited trading taylor francis group

doi pmcid pmc

conflict interest statement potential conflict interest reported author

abstract zhongguo yi xue ke xue yuan xue bao oct doi jissnx

effect proteasome subunit beta proliferationmigrationand invasion clear cell renal cell carcinoma cell via mitogenactivated protein kinase kinaseextracellular signalregulated kinase signaling pathway

article chinese abstract available chinese publisher

hao yf shi zheng jx zhao xt liu sl yang lj

department pharmacologyshanxi medical universitytaiyuan china key laboratory tumor immunology targeted drug development shanxi provinceshanxi medical universitytaiyuan china department biochemistry molecular biologyschool basic medical sciencesshanxi medical universitytaiyuan china

objective explore effect proteasome subunit beta psmb proliferationmigrationand invasion clear cell renal cell carcinoma ccrcc cell whether psmb promotes tumor progression activating mitogenactivated protein kinase kinase mekextracellular signalregulated kinase erk signaling pathway method cancer genome atlas employed analyze mrna level psmb ccrcc normal tissueand expression level psmb ccrcc tissue cell determined realtime quantitative pcrwestern blottingand immunohistochemistryfurthermorethe cell line stable overexpression knockdown psmb constructedthe cck assay colony formation assay employed examine cell proliferationand wound healing assay transwell assay employed examine invasion migration cellskyoto encyclopedia gene genome pathway enrichment performed analyze coexpressed gene psmbwestern blotting used measure phosphorylation level protein mekerk signaling pathwayfinallythe rescue experiment carried erk agonist cpaf result compared normal tissuethe ccrcc tissue showed upregulated mrna protein level psmb pwhich associated tnm stage patient ccrcc pcompared negative control groupoverexpression psmb promoted proliferation ppmigration invasion p achn cellsand knockdown psmb inhibited proliferation ppmigration invasion p achn cellsthe pathway enrichment analysis coexpressed gene psmb predicted mitogenactivated protein kinase signaling pathway pafter knockdown psmbo achn cell showed lowered phosphorylation level mek pp erk pp downregulated transcription level erk downstream factor cmyc ppcfos ppand cyclind ppcompared erk agonist cpaf groupthe psmb knockdown cpaf group showed inhibited proliferation ppmigration invasion p achn cell conclusion psmb may promote proliferationmigrationand invasion ccrcc cell activating mekerk signaling pathway

publisher spsmbccrccmekerk ccrccpsmb mrnapcrwestern blotpsmbccrccpsmbccktranswellpsmbwestern blotmekerkerkcpaf psmb mrnaccrccptnmppsmboachnppppsmboachnppppsmbppsmboachnmekpperkpperkcmycppcfosppcyclindpperkcpafpsmb cpafoachnppp psmbmekerkccrcc

doi jissnx indexed medline

abstract j gene med nove

integrative analysis genetic mechanism responsible bonefat imbalance osteoporosis

zhang z tao z zhang zhang z zhang w zhang x zhao j tao c zhou x

department orthopedics changzheng hospital second military medical university naval medical university shanghai china department orthopedic rehabilitation qingdao special serviceman recuperation center pla navy qingdao china district department orthopedics hospital pla navy qingdao china college basic medicine second military medical university naval medical university shanghai china

osteoporosis manifest adipocyte accrual osteoblast diminution within bone marrow however precise mechanism driving shift osteogenesis adipogenesis bone marrow mesenchymal stem cell bmscs remain largely undefined study harnessed power bioinformatic tool analyze gene expression pattern bmscs adipogenic differentiation osteoporosis using data gene expression omnibus geo repository gse gse complemented vitro vivo experiment validate finding five distinct expression profile differentially expressed gene across adipogenic timeline identified initial phase marked ribosome biogenesis rrna processing followed metabolism organic acid processing inorganic ion contrast terminal phase characterized lipid transport accumulation metabolism alongside inorganic cation metabolism thereby underscoring unique transcriptional signature early late stage adipogenic differentiation bmscs derived osteoporotic sample notable decline cellular proliferation diminished osteogenic capacity critically gene common adipogenesis osteoporosis bmscs predominantly involved negative regulation wnt signaling cellular proliferation key gene including socs myc cebpb fyn axin rxra identified show downregulation bmscs aged mouse subsequent vitro experiment validated regulatory influence rxra adipogenic osteogenic differentiation bmscs highlighting crucial role central modulator bone formation pathophysiology osteoporosis

john wiley son ltd

doi jgm indexed medline

abstract cancer gene ther nov online ahead print

novel pharmacologic inhibition lysinespecific demethylase potential therapeutic glioblastoma

shinjo k umehara niwa h sato katsushima k sato wang x murofushi suzuki mm koyama h kondo

division cancer biology center neurological disease cancer nagoya university graduate school medicine nagoya japan laboratory epigenetics drug discovery riken center biosystems dynamic research yokohama japan morphological information analysis laboratory kanagawa cancer center research institute yokohama japan drug discovery chemistry platform unit riken center sustainable resource science wako japan division cancer biology center neurological disease cancer nagoya university graduate school medicine nagoya japan kondoyutakaafmailnagoyauacjp center one medicine innovative translational research comit nagoya japan kondoyutakaafmailnagoyauacjp institute glycocore research igcore nagoya university nagoya japan kondoyutakaafmailnagoyauacjp contributed equally

lysinespecific demethylase lsdkdma pivotal epigenetic enzyme contributes several malignancy including malignant glioma lsd flavin adenine dinucleotide dependent histone demethylase specifically target histone h lysine k mono dimethylation hkme demethylation herein report development lsd inhibitor efficiently penetrates bloodbrain barrier effectively suppresses lsd enzymatic activity resulting depletion cell growth vitro glioma stem cell gscs mean halfmaximal inhibitory concentration ic vivo gsc orthotopic xenograft mouse model treatment robustly reduced expression stemnessrelated gene myc nestin gsc cell consistent chromatin immunoprecipitationsequencing revealed significant sdependent alteration hkmehkme status furthermore identified newly acquired hkme peak region treatment encompassed within superenhancer region altered hkmehkme status induced treatment affected expression gene related tumorigenesis data suggest targeting lsd could provide promising treatment option glioblastoma particularly due targeting gsc population

author

doi

abstract plo one nov e

tcf promotes apoptosis wntcatenin signaling pathway acute kidney injury via transcriptional regulation coxal

xi lu j qi h

department nephrology shanghai pudong new area people hospital shanghai china

background acute kidney injury aki still serious kidney illness high morbidity death rate crucial comprehend underlying molecular cause method bioinformatics analysis performed gse gse data set coxal screened role coxal hrtreated cell transcriptional regulation tcf assessed vitro experiment analyzed regulation coxal tcf proliferation apoptosis wntcatenin signaling pathway hrtreated cell result coxal hub gene downregulated aki sample hrtreated cell coxal overexpression inhibited apoptosis promoted cell proliferation coxal knockdown promoted apoptosis inhibited cell proliferation notably tcf exhibited significant positive correlation coxal tcf overexpressioninduced apoptosis lessened improved cell proliferation countered coxal knockdown according rescue study finding besides discovered tcf overexpression increased expression protein linked wntcatenin signaling pathway cmyc catenin cyclin underexpression coxal counteracted effect conclusion study revealed pivotal role coxal aki regulated tcf modulates wntcatenin signaling pathway highlighting potential therapeutic target

copyright xi et al open access article distributed term creative common attribution license permit unrestricted use distribution reproduction medium provided original author source credited

doi journalpone pmcid pmc indexed medline

conflict interest statement author declared competing interest exist

abstract integr biol camb jan zyae

network dynamic investigation omicsdatadriven circadianhypoxia crosstalk logical model gallbladder cancer reveals key therapeutic target combination

singh dwivedi

department bioengineering biotechnology birla institute technology mesra ranchi jharkhand india

recent finding cancer research pointed towards bidirectional interaction circadian hypoxia pathway however little known crosstalk mechanism work aimed investigate crosstalk network level utilizing omics information gallbladder cancer differential gene expression pathway enrichment analysis used selecting crucial gene pathway followed construction logical crosstalk model using ginsim functional circuit identification node perturbation performed significant node combination used investigate temporal behavior network maboss lastly model validated using published vitro experimentation four new positive circuit new axis viz bmal hif nanog responsible stemness identified triple node perturbation viza bmalclock ko e p e hif ko b p e hif ko myc e c hif ko myc e egfr ko model able inhibit cancer growth maintain homeostatic condition work provides architecture drug simulation analysis entrainment circadian rhythm vitro experiment chronotherapyrelated study insight box circadian rhythm hypoxia key dysregulated process fuelsup cancer growth present work developed gallbladder cancer gbc specific boolean model utilizing rnaseq data gbc dataset tissue specific interaction work adequately model bidirectional nature interaction previously illustrated experimental paper showing effect hypoxia dysregulation circadian rhythm influence disruption progression towards metastasis dynamical study model response different perturbation report novel triple node combination targeted efficiently reduce gbc growth network used generalized framework investigate different crosstalk pathway linked cancer progression

author published oxford university press right reserved permission please email journalspermissionsoupcom

doi intbiozyae indexed medline

abstract mod pathol nov online ahead print

proximal classic epithelioid sarcoma distinct molecular entity defined mycgata soxendothelial marker respectively

sigalotti l frezza sbaraglia del savio e baldazzi valenti b bellan e de benedictis doni gambarotti vincenzi b brunello baldi gg palmerini e pasquali ciuffetti varano v cappello f appolloni v pastrello c jurisica gronchi stacchiotti casali pg dei tos ap maestro r

unit oncogenetics functional oncogenomics centro di riferimento oncologico di aviano cro aviano irccs national cancer institute aviano italy department medical oncology fondazione irccs istituto nazionale dei tumori milan italy surgical pathology cytopathology unit department medicinedimed university padua school medicine padua italy department pathology azienda ospedale universit padova padua italy department pathology irccs istituto ortopedico rizzoli bologna italy department medical oncology universit campus biomedico di rom rome italy department oncology medical oncology unit istituto oncologico veneto iov irccs padua italy department medical oncology hospital prato azienda usl toscana centro prato italy osteoncology bone soft tissue sarcoma innovative therapy irccs istituto ortopedico rizzoli bologna italy department applied research technological development molecular pharmacology unit fondazione irccs istituto nazionale dei tumori milan italy italian sarcoma group fondazione irccs istituto nazionale dei tumori milan italy division orthopaedic surgery schroeder arthritis institute toronto canada data science discovery centre chronic disease krembil research institute toronto canada division orthopaedic surgery schroeder arthritis institute toronto canada data science discovery centre chronic disease krembil research institute toronto canada department medical biophysics computer science university toronto toronto canada institute neuroimmunology slovak academy science bratislava slovakia department sarcoma surgery fondazione irccs istituto nazionale dei tumori milan italy department medical oncology fondazione irccs istituto nazionale dei tumori milan italy department oncology haematooncology university milan milan italy unit oncogenetics functional oncogenomics centro di riferimento oncologico di aviano cro aviano irccs national cancer institute aviano italy electronic address rmaestrocroit

epithelioid sarcoma e rare tumor hallmarked loss inismarcb expression apart alteration little known biology e despite recent advance treatment prognosis e remains unsatisfactory elucidate molecular underpinnings e identify diagnostic biomarkers potential therapeutic vulnerability performed integrated omics profiling rna sequencing methylation array primary untreated es transcriptome methylome analysis identified two distinct molecular cluster essentially corresponded morphologic variant e classic e ce aggressive proximal e pe pe group characterized hyperactivation gata myc pathway extensive epigenetic rewiring associated ezh overexpression dna methylation gene expression analysis indicated striking similarity myc subgroup atrt another smarcbdeficient tumor implying shared molecular background potential therapeutic vulnerability conversely ce group exhibited endotheliallike molecular profile expression vascular gene elevated proangiogenic sox signaling immunohistochemistry validated overexpression chromatin regulator gata v ezh v pes vascular factor sox v ncadherin v ce therefore molecule emerge potential diagnostic tool fill gap represented lack e subtypespecific biomarkers summary study show pe ce represent distinct molecular entity defined mycgata soxendothelial molecular trait respectively besides providing insight biology e study pinpoint subtypespecific biomarkers potential therapeutic vulnerability

copyright author published elsevier inc right reserved

doi jmodpat

abstract mod pathol nov online ahead print

refining diagnostic subtypes peripheral tcell lymphoma using multiparameter approach

amador c weisenburger dd gomez bouska alshomrani sharma shah r greiner tc vega f rosenwald ott g feldman al jaffe e ozkaya n ondrejka sl cook jr raess pw savage kj slack gw song jy scott dw campo e rimsza lm khoury jd staudt lm chan wc iqbal j leukemia lymphoma molecular profiling project llmpp consortium

department pathology laboratory medicine university miami miller school medicine miami fl electronic address catalinaamadormedmiamiedu department pathology microbiology immunology university nebraska medical center omaha ne department pathology laboratory medicine university miami miller school medicine miami fl department hematopathology division pathology laboratory medicine ut md anderson cancer center institute pathology university wrzburg comprehensive cancer center mainfranken wrzburg germany department clinical pathology robertbosch krankenhaus dr margarete fischerbosch institute clinical pharmacology stuttgart germany department laboratory medicine pathology mayo clinic college medicine science rochester mn laboratory pathology center cancer research national cancer institute bethesda md pathology laboratory medicine institute cleveland clinic cleveland oh department pathology laboratory medicine oregon health science university portland center lymphoid cancer british columbia cancer vancouver bc canada department pathology city hope national medical center duarte ca hematopathology unit hospital clinic barcelona spain institute biomedical research august pi sunyer idibaps university barcelona barcelona spain department laboratory medicine pathology mayo clinic arizona scottsdale az metabolism branch center cancer research national cancer institute national institute health bethesda md department pathology microbiology immunology university nebraska medical center omaha ne electronic address jiqbalunmcedu

peripheral tcell lymphoma ptcl heterogeneous category many case unclassifiable designated ptclnot otherwise specified ptclnos gene expression profiling gep delineated two prognostic subtypes within ptclnos ptcltbx ptclgata characterized distinctive transcriptomes different prognosis evaluate pathologic feature subgroup ptcl case meet specific criterion welldefined tcell lymphoma entity underwent detailed pathologic immunophenotypic including tfh biomarkers gep analysis separating ptclnos n ptcltfh aka nodal ptcltfh no tfh lymphoma no n ptclnos case categorized ptclgata n ptcltbx n significant association p overall survival o reaffirmed histopathological assessment showed ptclgata case characterized monotonous mediumsized large transformed cell minimal tumor microenvironment tme compared ptcltbx case consisted pleomorphic cell polymorphous tme p gep analysis validated tme distinction immunophenotypic analysis showed ptclgata case predominantly cdcd associated significantly higher lef myc cd expression p ptcltbx displayed diverse biomarker profile two subgroup one expressing cytotoxic antigen enriched cdcd cdcd phenotype another lacking cytotoxic marker showing cdcd phenotype increased icos expression devoid tfh marker ptcltfh case correlated angioimmunoblastic tcell lymphoma aitl gene signature eberpositive cell ptclgata ptcltbx case subset morphologic feature aitl p study highlight unique morphologic phenotypic variation within newlyidentified ptcl subtypes enable precise diagnosis tailored therapeutic strategy future

copyright published elsevier inc

doi jmodpat

abstract lung cancer oct online ahead print

putative mechanism primary resistance egfrtargeted therapy retrospective study

tu x lu z hei f zhang wang x chen fan f xu j zhang x guo k

department clinical laboratory yellow river sanmenxia affliated hospital henan university science technology sanmenxia pr china state key laboratory neurology oncology drug development jiangsu simcere pharmaceutical co ltd jiangsu simcere diagnostics coltd pr china nanjing simcere medical laboratory science co ltd nanjing pr china department oncology ulanqab central hospital inner mongolia autonomous region pr china department oncology jiayu hospital zhongnan hospital wuhan university people hospital jiayu county xianning pr china state key laboratory neurology oncology drug development jiangsu simcere pharmaceutical co ltd jiangsu simcere diagnostics coltd pr china nanjing simcere medical laboratory science co ltd nanjing pr china cancer center first affiliated hospital jinzhou medical university jinzhou pr china department oncology pingyao county hospital traditional chinese medicine shanxi pr china department oncology yellow river sanmenxia affliated hospital henan university science technology sanmenxia pr china state key laboratory neurology oncology drug development jiangsu simcere pharmaceutical co ltd jiangsu simcere diagnostics coltd pr china nanjing simcere medical laboratory science co ltd nanjing pr china cancer center first affiliated hospital jinzhou medical university jinzhou pr china electronic address xingzhangsimceredxcom department oncology yellow river sanmenxia affliated hospital henan university science technology sanmenxia pr china electronic address guokefengcom

background advanced lung adenocarcinoma luad patient egfr mutation often experience resistance firstline epidermal growth factor tyrosine kinase inhibitor egfrtkis therapy nonetheless mechanism biomarkers primary resistance remain unclear exploration independent prognostic factor help clinician identify patient may respond egfrtkis select appropriate treatment strategy method retrospective study involving patient stage iv luad harboring common sensitizing egfr mutation exon deletion lr mutation received egfrtkis firstline therapy performed participant tested dnatargeted sequencing baseline sample patient progressionfree survival pfs month cohort c primary resistance patient pfs month cohort c poor response without known mutation associated resistance patient pfs month cohort c normal result commonly mutated gene baseline patient prior treatment within entire study population tp myc cdkna muc rbm baseline characteristic except proportion patient egfr lr mutation exon deletion c plus c compared c p significantly different among cohort frequency pikcg stk epa rara btg variation significantly higher c primary resistance group multivariate cox analysis revealed pikcg hr ci p stk hr ci p epa hr ci p btg amplification hr ci p significantly associated shorter pfs conclusion genomic landscape varies significantly among patient luad considered making personalized treatment decision information could provide insight molecular change effect clinical treatment diverse patient luad harboring sensitizing egfr mutation

copyright author published elsevier bv right reserved

doi jlungcan

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract mol ther oct online ahead print

nmethyladenosine modification activates serine synthesis pathway mediate therapeutic resistance liver cancer

chan ff kinleung kwan k seoung dh waiching chin oilin ng chaklui wong c wong cm

state key laboratory liver research department pathology school clinical medicine li ka shing faculty medicine university hong kong hong kong state key laboratory liver research department pathology school clinical medicine li ka shing faculty medicine university hong kong hong kong centre oncology immunology hong kong science park hong kong sar china state key laboratory liver research department pathology school clinical medicine li ka shing faculty medicine university hong kong hong kong electronic address jackwongpathologyhkuhk

metabolic adaptation serf significant driving force cancer growth pose substantial obstacle cancer therapy herein unravelled role mediated serine synthesis pathway regulation hepatocellular carcinoma hcc development therapeutic resistance demonstrated highly specific inhibitor stm treatment effectively inhibited hcc cell line growth suppressed spontaneous hcc formation mouse driven liver specific tp knockout myc overexpression using gloriseq delineated singlebase resolution landscape human hcc cell line interestingly identified three core enzyme serine synthesis pathway phgdh psat psph novel target mettlmediated modification ssp gene modification recruited igfbp reader stabilize mrna transcript thereby enhancing mrna protein expression hcc cell importantly gloriseq data revealed sorafenibresistant hcc cell elevated modification ssp gene promote protein expression antioxidant production stm treatment attenuated serine synthesis pathway induced oxidative stress sensitized hcc cell sorafenib lenvatinib treatment conclusion finding suggest targeting could potential therapeutic strategy hcc treatment

copyright published elsevier inc

doi jymthe

abstract biorxiv preprint oct doi

inhibition uben regulatory tcells boost immunity cancer

miao w jain v han jin yj beasley gm starczysnowski dt gregory sg zhang jy

regulatory treg cell prevent autoimmunity facilitate cancer immune evasion depletion tregs promising cancer therapy risk autoimmune reaction hamper clinical translation demonstrate temporally induced deletion uben tregs uben tregko adult mouse result robust expansion activation cytotoxic cd tcells response cancer cell challenge producing longlasting survival benefit without autoimmune complication antitumor effect persists following adoptive tcell transfer tcelldeficient ragknockout mouse singlecell transcriptomic analysis revealed uben deletion shifted immunosuppressive tregs effectorlike tcells shift characterized downregulation cmyc target gene resembling observed tumorinfiltrating tregs melanoma patient analysis confirm uben maintains cmyc protein stability via suppression kubiquitinmediated proteasomal degradation taken together study uncover hitherto unexplored potentially druggable ubencmyc signaling axis eradicate tregenabled cancer immune escape

doi pmcid pmc

abstract biorxiv preprint oct doi

notch drive tumor plasticity metastasis hepatocellular carcinoma

lindblad ke donne r liebling bresnahan e barcenavarela lozano park e giotti b burn fiel mi bravocordero jj tsankov lujambio

liver cancer third leading cause cancerrelated mortality worldwide two main subtypes hepatocellular carcinoma hcc accounting case cholangiocarcinoma caa notch pathway regulates intrahepatic development bile duct lined cholangiocytes also upregulated hccs better understand role notch hcc developed novel mouse model driven activated notch intracellular domain nicd myc overexpression hepatocytes using hydrodynamic tail vein injection method establishing primary liver tumor generated novel murine model liver cancer harboring myc overexpression notch activation characterized model histopathologically well transcriptomically utilizing bulk single cell rnasequencing mycnicd tumor displayed combined hcccca phenotype temporal plasticity early timepoints histology predominantly cholangiocellular progressed mainly hepatocellular hepatocellular component enriched mesenchymal gene gave rise lung metastasis metastatic cell enriched tgfb vegf pathway inhibition significantly reduced metastatic burden novel mouse model uncovered notch driver temporal plasticity metastasis hcc latter part mediated angiogenesis tgf pathway

doi pmcid pmc

abstract biorxiv preprint oct doi

expressiondriven genetic dependency reveals target precision medicine

elmas layden hm elli jd bartlett ln zhao x kawabataiwakawa r obinata h hiebert sw huang kl

cancer cell heterogeneous harboring distinct molecular aberration dependent different gene survival proliferation successful targeted therapy developed based driver dna mutation many patient tumor lack druggable mutation limited treatment option hypothesize new precision oncology target may identified expressiondriven dependency whereby cancer cell high expression targeted gene vulnerable knockout gene introduce bayesian approach beacon identify target jointly analyzing global transcriptomic proteomic profile genetic dependency data cancer cell line across tissue lineage beacon identifies known druggable gene eg bcl erbb egfr esr myc revealing new target confirmed mrna proteinexpression driven dependency notably identified gene show overall fold enrichment approved drug target enrich druggable oncology target fold experimentally validate depletion grhl tp pax effectively reduce tumor cell growth survival dependent cell overall present catalog expressdriven dependency target resource identifying novel therapeutic target precision oncology

doi pmcid pmc

abstract plant biotechnol j nov online ahead print

wheat tapylinvolved signalling pathway impact plant drought response regulating distinct osmotic stressassociated physiological index

zhang zhao hou x zhang c wang z zhang j liu x shi x duan w xiao k

state key laboratory north china crop improvement regulation baoding hebei china college agronomy agricultural university hebei baoding hebei china hebei key laboratory crop cultivation physiology green production institute cereal oil crop hebei academy agriculture forestry science shijiazhuang hebei china

abscisic acid aba signalling pathway play crucial role plant response drought stress study aimed characterize impact aba signalling module consisted tapyl downstream partner triticum aestivum plant drought adaptation result showed tapyl protein contains conserved motif target plasma membrane nucleus sorted endoplasmic reticulum addition tapyl transcript root leaf significantly upregulated response drought stress conducted glucuronidase gu histochemical staining analysis transgenic plant carrying truncated tapyl promoter suggested ciselements associate aba drought response abre dre recognition site myb myc regulating gene transcription drought condition using protein interaction assay ie yeast twohybrid bimolecular fluorescence complementation bifc coimmunoprecipitation coip vitro pulldown demonstrated interaction intermediate segment tapyl intermediate segment tappc nterminus tasnrk cterminus transcription factor tabzip wheat indicating involvement tapyl constitution aba signalling module namely tapyltappctasnrktabzip transgene analysis revealed tapyl tasnrk tabzip positively regulated drought response tappc negatively regulated gene closely associated regulation stoma movement osmolyte accumulation ro homeostasis electrophoretic mobility shift emsa transcriptioal activation assay indicated tabzip interacted promoter tapcs taslac tacat activated transcription gene regulated proline biosynthesis stoma movement ro scavenging upon drought signalling respectively furthermore found transcript tapyl stressresponsive gene positively correlated yield wheat cultivar field drought condition altogether finding suggest tapylinvolved signalling pathway significantly regulates drought response modulating osmotic stressassociated physiological process aestivum

author plant biotechnology journal published society experimental biology association applied biologist john wiley son ltd

doi pbi

abstract cancer biol ther dec doi epub nov

gdx inhibits occurrence progression breast cancer negatively modulating activity stat

chen z xu l lin huang h long q liu j

department oncology first affiliated hospital dalian medical university dalian liaoning china department breast surgery first affiliated hospital hainan medical university haikou hainan china department hematology first affiliated hospital hainan medical university haikou hainan china department ultrasound hainan woman childrens medical center haikou hainan china

aim elucidate biological functionality regulatory mechanism gdx breast cancer bc method examination gdx expression human bc tissue cell line conducted immunohistochemical ihc western blot cell proliferation capacity assessed via cck colony formation assay cell migration determined wound healing assay expression level bclxl cyclin cmyc gene quantified using rtqpcr western blot vivo tumor growth evaluated nude mouse xenografted mdamb cell overexpressing gdx mouse model gdxdeficient bc established observe impact gdx bc formation metastasis dualluciferase reporter assay immunofluorescence employed confirm interaction gdx stat western blot employed validate influence gdx overexpression phosphorylation process stat result gdx exhibited low expression cancer tissue bc patient cell line mdamb mcf cell overexpressing gdx displayed notable reduction proliferation diminished migratory capability accompanied downregulated mrna protein expression bclxl cyclin cmyc xenograft mouse model heightened gdx expression correlated decelerated vivo tumor growth furthermore mouse deteleing gdx quantity weight tumor increased along evident pulmonary metastasis mechanistically stat emerged downstream target gene gdx conclusion gdx exerts inhibitory effect initiation progression bc negatively modulating phosphorylation stat

doi pmcid pmc indexed medline

conflict interest statement potential conflict interest reported author

abstract adv med sci oct doi jadvms online ahead print

recurrent hepatocellular carcinoma associated enrichment myc target gene set elevated high confidence deleterious mutation alternative splicing ddb brca transcript

karaosmanolu

department biology kamil zda faculty science karamanolu mehmetbey university brahim ktem avenue karaman trkiye electronic address oguzhankaraosmanogluwindowslivecom

purpose recurrence main cause hepatocellular carcinoma hcc related death underlying recurrence biology better understood comparative analysis complete set transcript recurrent nonrecurrent hcc study transcriptomic data gse male patient diagnosed either recurrent nonrecurrent hcc reanalyzed identify deregulated pathway somatic mutation fusion transcript alternative splicing event immune context recurrent hcc material method deseq used differential expression analysis mutect somatic mutation analysis arriba starfusion fusion transcript analysis rmats alternative splicing analysis result result revealed myc target gene set hallmarkmyctargetsv hallmarkmyctargetsv significantly enriched recurrent hcc among myc target cbx nop cdk npm mcm mcm pag upregulation significantly associated poor survival somatic mutation analysis demonstrated number high confidence deleterious mutation significantly increased recurrent hcc alternative splicingmediated production nonfunctional ddb oncogenic brca dq discovered recurrent hcc finally cd tcells significantly decreased recurrent hcc conclusion result indicated enrichment myc target gene set one critical factor lead development recurrent hcc addition elevated deleterious mutation number alternative spliced ddb brca isoforms identified prominent contributor increasing genomic instability male patient recurrent hcc

copyright published elsevier bv

doi jadvms

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract jto clin re rep aug

rearranged transfection rearrangement detection fluorescence situ hybridization compared technique nsclc

mc leer mondet j magnat n mersch giovannini emprou c toffart ac sturm n lantujoul benito

universit grenoble alpes grenoble france service danatomie et cytologie pathologiques ple de biologie et pathologie chu grenoble alpes grenoble france institute advanced bioscience universit grenoble alpes grenoble france timcimag universit grenoblealpes la tronche france clinique hospitalouniversitaire de pneumologie physiologie ple thorax et vaisseaux chu grenoble alpes grenoble france cancer research center lyon centre lon brard lyon france medical affair oncology eli lilly suisse sa dubai united arab emirate

introduction ret rearrangement occur nsclcs since clinically validated ret antibody currently available fluorescence situ hybridization fish often used screening tool identify patient likely benefit rettargeted therapy study performed comprehensive review publication retrearrangement testing performed fish compared method result data method finding electronic search publication using retfish lung cancer compared result obtained grenoble university hospital egfr kras alk rosnegative nsclcs tested ret breakapart fish confirmed rnasequencing rnaseq result publication using retfish analysis pertained patient lung cancer often used positivity threshold six publication compared retfish least one molecular technique least eight sample concordance variable fishpositive case regarding data analyzed sample positive retfish concordance retfish rnaseq retfish positive sample conclusion overall existing literature data suggest retfish testing used rapid screening ret rearrangement nsclc nevertheless using orthogonal technique rnaseq confirm retfishpositive case essential ensuring patient likely benefit rettarget therapy receive treatment

author

doi jjtocrr pmcid pmc

conflict interest statement dr mc leer declared consulting fee janssencilag eli lilly takeda jfr access pfizer payment presentation amgen astrazeneca cancerodigest edimark janssencilag support attending meeting amgen astrazeneca janssencilag pfizer dr toffart declared consulting fee astrazeneca bristolmyers squibb amgen ipsen janssen merck sharp dohme pfizer roche sanofi takeda payment presentation astrazeneca bristolmyers squibb amgen ipsen janssen merck sharp dohme pfizer roche sanofi takeda payment expert testimony astrazeneca bristolmyers squibb amgen ipsen janssen merck sharp dohme pfizer roche sanofi takeda support attending meeting astrazeneca pfizer roche takeda dr benito fulltime employee eli lilly co remaining author declare conflict interest

abstract front endocrinol lausanne oct doi fendo

deciphering role lipid metabolismrelated gene alzheimers disease machine learning approach integrating traditional chinese medicine

wu k liu q long k duan x chen x zhang j li l li b

department geriatrics hospital chengdu university traditional chinese medicine chengdu sichuan china

background alzheimers disease ad represents progressive neurodegenerative disorder characterized accumulation misfolded amyloid beta protein leading formation amyloid plaque aggregation tau protein neurofibrillary tangle within cerebral cortex role carbohydrate particularly apolipoprotein e apoe pivotal ad pathogenesis due involvement lipid cholesterol metabolism status genetic predisposition factor disease despite significance mechanistic contribution lipid metabolismrelated gene lmgs ad remain inadequately elucidated research endeavor seek bridge gap pinpointing biomarkers indicative earlystage ad emphasis linked immune cell infiltration end advanced machinelearning algorithm data derived gene expression omnibus geo database employed facilitate identification biomarkers method differentially expressed gene degs identified comparing gene expression profile healthy individual alzheimers disease ad patient using data two gene expression omnibus geo datasets gse gse functional enrichment analysis conducted elucidate biological relevance degs ensure reliability result sample randomly divided training validation set analysis focused lipid metabolismrelated degs lmdegs explore potential biomarkers ad machine learning algorithm including support vector machinerecursive feature elimination svmrfe least absolute shrinkage selection operator lasso regression model applied identify key gene biomarker additionally immune cell infiltration relationship gene biomarker assessed using cibersort algorithm integrated traditional chinese medicine itcm database also referenced identify chinese medicine related lipid metabolism possible connection ad comprehensive strategy aim integrate modern computational method traditional medicine deepen understanding ad underlying mechanism result study identified gene pool lipid metabolismrelated gene lmgs significantly associated autophagy immune response mechanism application lasso svmrfe machinelearning technique four genescholine acetyl transferase chat member ra oncogene family raba acylcoa binding domaincontaining protein acbd alphagalactosidase glaemerged potential biomarkers alzheimers disease ad gene demonstrated strong therapeutic potential due involvement critical biological pathway notably nine chinese medicine compound identified target marker gene offering novel treatment approach ad cerna network analysis revealed complex regulatory interaction involving gene underscoring importance ad pathology cibersort analysis highlighted potential link change immune microenvironment chat expression level ad patient providing new insight immunological dimension disease conclusion discovery gene marker offer substantial promise diagnosis understanding alzheimers disease ad however investigation necessary validate clinical utility study illuminates role lipid metabolismrelated gene lmgs ad pathogenesis offering potential target therapeutic intervention enhances grasp ad complex mechanism pave way future research aimed refining diagnostic treatment strategy

copyright wu liu long duan chen zhang li li

doi fendo pmcid pmc indexed medline

conflict interest statement author declare research conducted absence commercial financial relationship could construed potential conflict interest

abstract transl lung cancer re oct doi tlcr epub oct

switchsucrose nonfermentable complexdeficient pulmonary neoplasm clinicopathologic characteristic outcome radiotherapy immunotherapy

gu lai yang j zhang j fan x zheng q

department radiation oncology shanghai cancer center fudan university shanghai china department oncology shanghai medical college fudan university shanghai china shanghai clinical research center radiation oncology shanghai china shanghai key laboratory radiation oncology shanghai china xiaogan hospital affiliated wuhan university science technology xiaogan china department pathology fudan university shanghai cancer center shanghai china contributed equally

background switchsucrose nonfermentable swisnf complex multisubunit chromatin remodeler linked aggressive tumor deficient accurate identification swisnf expression status crucial tailoring targeted therapy previous study efficacy immunotherapy swisnfdeficient swisnfd pulmonary tumor primarily focus nonsmall cell lung cancer nsclc limited data modality like radiotherapy study aim analyze clinicopathological characteristic prognostic factor swisnfd pulmonary neoplasm including nsclc undifferentiated tumor evaluate effectiveness radiotherapy immunotherapy providing foundation improved treatment strategy prognostic assessment method patient data swisnfd pulmonary neoplasm collected fudan university shanghai cancer center assessing arida smarca smarca smarcb subunit expression via immunohistochemistry retrospective analysis survival treatment result result study analyzed swisnfd pulmonary neoplasm swisnfd cancer patient january august mostly male smoker showing high malignancy clinicopathologic feature consistent across patient various swisnf subunit deficiency tp common comutated gene followed stk cdkna kras apc egfr key prognostic factor overall survival o distant metastasis radiotherapy immunotherapy immunotherapy improved year o rate p krasmutated patient immunotherapy showed lower year survival rate v p radiotherapy increased year o rate p patient treated immunotherapy benefited radiotherapy median o month v estimable ne p average day radiotherapy immunotherapy conclusion swisnfd pulmonary neoplasm whether multiple single subunit loss exhibit similar clinicopathological characteristic radiotherapy immunotherapy effective treatment patient combination radiotherapy immunotherapy may offer synergistic effect

ame publishing company right reserved

doi tlcr pmcid pmc

conflict interest statement conflict interest author completed icmje uniform disclosure form available httpstlcramegroupscomarticleviewtlcrcoif author conflict interest declare

abstract physiol mol biol plant oct doi epub oct

arabidopsis gdh gdh gene double knockout result staygreen phenotype darkinduced senescence

garnik ey vilyanen dv vlasova aa tarasenko vi konstantinov ym

siberian institute plant physiology biochemistry sb ra lermontova str irkutsk russia present address institute basic biological problem ra federal research center pushchino scientific center biological research ra prospekt nauki pushchino moscow region russia present address irkutsk state university karl marx str irkutsk russia

yellowing first visually observable sign plant leaf senescence found arabidopsis double knockout mutant gdhgdh gene nadhdependent glutamate dehydrogenase retains green color leaf staygreen phenotype darkinduced senescence contrast wildtype plant whose leaf turn yellow gdhgdh plant exposed dark four day demonstrate slower chlorophyll degradation wildtype plant condition well dysregulation chlorophyll breakdown gene encoding chlorophyll b reductase mgdechelatase pheophytinase pheophorbide oxygenase slowed degradation chlorophyll b gdhgdh plant significantly alters chlorophyll ab ratio ion leakage mutant plant increase significantly four eight day darkness correlating premature death period discovered fact suggest functional connection activity nadhdependent glutamate dehydrogenase darkinduced senescence progress arabidopsis

prof h srivastava foundation science society springer nature licensor eg society partner hold exclusive right article publishing agreement author rightsholders author selfarchiving accepted manuscript version article solely governed term publishing agreement applicable law

doi pmcid pmc

conflict interest statement conflict interestthe author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract j dairy re nov online ahead print

transcriptomic analysis reveals prolactin modulates casein synthesis mechanism bovine mammary epithelial cell

zhang xu z wang x hou x yang liu lin

key laboratory animal cellular genetics engineering heilongjiang province northeast agricultural university harbin china key laboratory dairy science education ministry northeast agricultural university harbin china

research communication screened identified differentiated expressed gene bovine mammary epithelial cell bmecs upon prolactin prl stimulation prl gml increased casein synthesis bmecs milk protein synthesis capacity rna sequencing rnaseq used screen differentially expressed gene degs total degs upregulated downregulated identified prlstimulated group control group gene ontology enrichment analysis showed upregulated gene primarily associated cell function metabolic process biological regulatory process pathway enrichment analysis showed upregulated gene mainly enriched jakstat rap ra notch signaling pathway widely involved cell proliferation differentiation milk component synthesis study provides initial understanding change gene expression bmecs prlstimulation determined rnaseq transcriptomic analysis thereby enhancing knowledge molecular regulation lactation metabolism

doi

abstract mol med nov

mgst facilitates novel krasgd inhibitor resistance krasgdmutated pancreatic ductal adenocarcinoma inhibiting ferroptosis

xu c lin w zhang q wang x guo zhu g zhou z song w zhao z jiao wang x du c

state key laboratory molecular oncology national cancer centernational clinical research center cancercancer hospital chinese academy medical science peking union medical college beijing china institute cancer research henan academy innovation medical science zhengzhou henan china department thoracic surgery national cancer centernational clinical research center cancercancer hospital chinese academy medical science peking union medical college beijing china harrow international school shenzhen qianhai shenzhen china state key laboratory molecular oncology national cancer centernational clinical research center cancercancer hospital chinese academy medical science peking union medical college beijing china wangxbcicamsaccn institute cancer research henan academy innovation medical science zhengzhou henan china wangxbcicamsaccn department medical oncology national cancer centernational clinical research center cancercancer hospital chinese academy medical science peking union medical college beijing china retinadcxvipcom contributed equally

background pancreatic ductal adenocarcinoma pdac highly lethal cancer low year survival rate treatment option pdac patient limited recent study shown promising result mrtx krasgd inhibitor demonstrated potent antitumor activity various type tumor krasgd mutation resistance kras inhibitor frequently occurred one main reason treatment failure understanding resistance mechanism novel kras inhibitor crucial ensure sustained durable remission method two krasgd inhibitor mrtxresistant pdac cell line established vitro resistance mechanism krasgd inhibitor mrtx pdac vitro vivo characterized rna sequencing reverse transcript polymerase chain reaction cytotoxicity test plasmid transfection lentivirus transfection lipid peroxidation detection malondialdehyde level detection glutathione level detection western blot immunofluorescence nude mouse tumorigenesis experiment immunohistochemistry result bioinformatics analysis transcriptome sequencing showed ferroptosis involved resistant effect krasgd inhibitor treatment mgst key molecule mrtxinduced ferroptosis increased expression mgst weakened cytotoxicity mrtx inhibiting lipid peroxidationinduced ferroptosis krasgd inhibitorresistant pdac cell knockdown overexpression mgst conferred sensitivity resistance krasgd inhibitor mrtx respectively mechanismly increased nuclear localization higher level active catenin observed mrtxresistant pdac cell contributed higher mgst expression knockdown ctnnb tcf decreased mgst expression additionally found pkf antagonist catenintcf complex repressed mgst expression vitro vivo model synergistic effect observed combining mrtx pkf krasgd inhibitor mrtxresistant pdac cell tumor conclusion data showed krasgd inhibitor mrtx combined pkf could enhance effectiveness mrtx treatment response induction ferroptosis via inhibiting mgst expression mrtxresistant pdac cell tumor evidence may provide promising strategy overcome krasgd inhibitor mrtx resistance pdac patient krasgd mutation

author

doi sy indexed medline

abstract front oncol oct

potential role nextgeneration sequencing identifying met amplification disclosing resistance mechanism nsclc patient osimertinib resistance

xiao x xu r lu j xin b wang c zhu k zhang h chen x

school physic changchun university science technology changchun china research development department shanghai rightongene biotechnology co ltd shanghai china department respiratory critical care medicine shanghai chest hospital shanghai jiao tong university school medicine shanghai china school life science technology changchun university science technology changchun china

purpose osimertinib one thirdgeneration egfrtyrosine kinase inhibitor tkis designed target egfr tm mutation significantly improves prognosis lung cancer however drug resistance still happens met amplification responsible one main cause fluorescence situ hybridization fish gold standard met amplification detection fundamentally limited observer subjectivity herein assessed value nextgeneration sequencing ng method met amplification detection nonsmall cell lung cancer nsclc well revealed mutation profiling nsclc patient osimertinib resistance provide valuable clue mechanism resistance method total cancer tissue sample nsclc patient time progression following osimertinib submitted ng tissue tested fish simultaneously fish result gold standard enumeration algorithm applied establish optimal model identifying met amplification using gene copy number gcn data result optimal model identifying met amplification constructed based gcn met braf cdk cypa achieved overall agreement fish performed well identifying met amplification except polysomy sensitivity specificity inconsistency ng fish occurred mainly polysomy subtype met gcn could reliably recognized ng moreover frequently mutated gene nsclc patient osimertinib resistance egfr followed tp nrg pikca atm known resistance mechanism including met amplification egfr c lqr tp cdk cdk cdkna braf kras nra pikca mutation also disclosed cohort conclusion ng assay achieve high concordance fish met amplification detection advantage portraying various genetic alteration worthy clinical promotion

copyright xiao xu lu xin wang zhu zhang chen

doi fonc pmcid pmc

conflict interest statement author xx rx bx cw kz employed company shanghai rightongene biotechnology co ltd remaining author declare research conducted absence commercial financial relationship could construed potential conflict interest

abstract front oncol oct

comprehensive liquid biopsy analysis monitoring nsclc patient secondline osimertinib treatment

ntzifa marras kallergi g kotsakis georgoulias v lianidou e

analysis circulating tumor cell lab lab analytical chemistry department chemistry national kapodistrian university athens athens greece laboratory biochemistrymetastatic signaling section genetics cell biology development department biology university patras patras greece department medical oncology general university hospital larissa larissa greece first department medical oncology metropolitan general hospital athens cholargos greece

background heterogeneous complex genetic landscape nsclc impact clinical outcome patient eventually develop resistance osimertinib liquid biopsy lb analysis minimally invasive approach key step efficiently identify resistance mechanism adjust proper subsequent treatment material method present study combined plasmacfdna ctc analysis nsclc patient sample collected treatment progression disease pd detected molecular alteration dna mutation egfr pikca kras gc braf dna methylation rassfa brms foxa slfn shisa rar wif rassf apc gene expression ck ck ck axl twist pdl pim vimentin aldh bm chromosomal level met amplification possible resistance mechanism druggable target also studied expression pdl single ctc using immunofluorescence result case tm resistance egfr mutation detected baseline ctc corresponding plasma cfdna pikca mutation detected plasmacfdna corresponding ctc kras gc braf mutation detected sample analyzed met amplification detected ctc two patient treatment whereas amplification detected ctc three patient baseline one patient pd dna methylation analysis revealed low concordance ctc cfdna indicating complementary information obtained parallel lb analysis result gene expression analysis indicated high rate vimentinpositive ctc detected time point osimertinib moreover increased number nsclc patient pd harboring ctc positive pdl axl pim expression detected ctc treatment suggesting new possible therapeutic strategy discussion result reveal comprehensive liquid biopsy analysis efficiently represent heterogeneous molecular landscape provide prominent information subsequent treatment nsclc patient pd since druggable molecular alteration detected ctc

copyright ntzifa marras kallergi kotsakis georgoulias lianidou

doi fonc pmcid pmc

conflict interest statement author declare research conducted absence commercial financial relationship could construed potential conflict interest author declared editorial board member frontier time submission impact peer review process final decision

abstract funct integr genomics nov

breast cancer genomic analysis reveal gene mutation signaling network

manjunath gk sharma nashier vasanthaiah jha bage mitra goyal p neerathilingam kumar

manipal academy higher education mahe manipal karnataka india institute bioinformatics international technology park whitefield bangalore karnataka india department biotechnology school life science central university rajasthan ajmer rajasthan india manipal academy higher education mahe manipal karnataka india abhishekibioinformaticsorg institute bioinformatics international technology park whitefield bangalore karnataka india abhishekibioinformaticsorg

breast cancer bc commonly diagnosed cancer predominant cause death woman bc complex disorder exploration several type bc omic data highlighting gene perturbation signaling cellular mechanism needed collected mutational data bc sample using cbioportal classified bc gene mutated sample five tier bctieriv subjected pathway proteinprotein network analysis using enrichr string respectively bctieri posse bc gene mutational frequency gene possessing frequency namely pikca tp gata cdh muc next seven bc gene kmtc ttn mapk syne ahnak usha ryr pathway analysis revealed five top bc pathway pikakt tp notch hippo ra pathway found bc panel share seven gene finding show bc arises genetic disruption evident bc signaling protein network

author exclusive licence springerverlag gmbh germany part springer nature

doi sy indexed medline

abstract sci rep nov

kras gc mutation nsclc small genetic center insight sotorasib therapy response potential

eser hekimoglu g yarar mh canbek ozcelik

department medical genetics umraniye education research hospital university health science istanbul turkey department histology embryology hamidiye international faculty medicine university health science istanbul turkey gulamhekimoglusbuedutr department medical oncology umraniye education research hospital university health science istanbul turkey

lung cancer remains significant health challenge characterized aberrant tissue growth within pulmonary system early carcinogenic event often involve genomic instability emergence mutator phenotype study aimed explore mutator phenotype patient diagnosed nonsmallcell lung cancer nsclc rna isolation formalinfixed paraffinembedded ffpe tissue sample performed using promega reliaprep rna miniprep system facilitating gene amplification relevant cancer archer fusionplexcomprehensivethyroid lung ctl kit nextgeneration sequencing ng illumina nextseq platform enabled comprehensive analysis target area utilizing archer analysis software secondary analysis involving data cleansing alignment variantfusion identification executed human reference genome hg grch expression pattern visualized using heatmap graphic finding revealed notable presence kras gene mutation approximately nsclc patient among mutation gc variant predominant followed gv gd variant notably patient harboring gc variant responded favorably sotorasib medication result underscore importance mutational profiling targeted therapeutic approach managing nsclc particularly highlighting promising efficacy sotorasib gcmutated case

author

doi pmcid pmc indexed medline

conflict interest statement author declare competing interest

abstract mol biol rep nov

clinical significance potential mechanism hsacirc acute respiratory distress syndrome complicated pulmonary fibrosis

zhang rong l long g huang f zhang q yang x sun h ji c ye rh

department dermatology postdoctoral station clinical medicine third xiangya hospital central south university changsha hunan china wuhan university taikang medical school school basic medical science wuhan hubei province people republic china department emergency guizhou provincial people hospital zhongshan east road guiyang guizhou china longguangwencom department emergency guizhou provincial people hospital zhongshan east road guiyang guizhou china department respiratory critical care medicine first affiliated hospital zhejiang chinese medical university youdian road shangcheng district hangzhou zhejiang china yeruihaicom contributed equally

background acute respiratory distress syndrome ards serious acute lung injury develop pulmonary fibrosis plf circular rna circrnas regulatory network ards important study explored role hsacirc occurrence ards development plf method hsacirc level verified serum sample ards patient without plf diagnostic value evaluated roc cox regression analysis performed identify plfrelated factor downstream target gene predicted online function pathway key gene annotated go kegg pathway analysis proteinprotein interaction ppi analysis performed examination protein interaction result qrtpcr determined downregulation hsacirc serum ards plf patient hsacirc differentiate ards control independently related development plf nine targeted related mirnas integrated dysregulated mirnas gse dataset clinically mirp mirna significantly different ards plf group determined target hsacirc target gene mirp predicted integrated ards plfrelated gse gse datasets go kegg pathway analysis identified ra signaling pathway commonly enriched pathway overlapped gene conclusion present result identified differentially expressed hsacirc ards plf suggested possible molecular mechanism hsacircmirp axis

author exclusive licence springer nature bv

doi indexed medline

abstract bioimpacts epub mar

association tumour mutation burden prognosis clinical significance stage iii gastric cancer

han yl chen l wang xn xu ml qin r gong fm sun p liu hy teng zp li zx dai gh

department general surgery first medical centre chinese pla general hospital beijing china department oncology pla rocket force characteristic medical centre beijing china department oncology fifth medical center chinese pla general hospital beijing china department general surgery air force hospital northern theater pla shenyang china department gastroenterology hospital pla beijing china

introduction explore correlation tumour mutation burden tmb prognosis clinical significance among patient stage iii gastric cancer gc method patient stage iii gc divided high tmb low tmb group study cohort patient cancer genome atlas tcga cohort patient study cohort nextgeneration sequencing used detect mutated gc gene obtain tmb data tcga cohort gene set enrichment analysis performed relationship tmb prognosis clinicopathologic factor analysed western blot quantitative realtime polymerase chain reaction used detect expression level protein gene cell viability measured using methyl thiazolyl tetrazolium transwell cell assay result patient high tmb group better overall survival o rate patient low tmb group cohort tmb associated age mutation signature mutation signature cox regression analysis revealed age tmb independent prognosis factor furthermore gene highfrequency mutation significantly enriched rtkras notch signalling pathway activation pathway lower high tmb compared low tmb group proliferation migration ability gc cell showed similar pattern tmb group conclusion patient high tmb group better o rate patient low tmb group gene highfrequency mutation significantly enriched rtkras notch pathway hence tmb could serve prognosis biomarker potential clinical significance

author

doi bi pmcid pmc

conflict interest statement author declare competing interest work

abstract gene oct online ahead print

analysis rosmarinic acid synthase ra gene family functional study smras salvia miltiorrhiza

xin zhan h kang h li q fu f han l hua w cao x

key laboratory ministry education medicinal resource natural pharmaceutical chemistry national engineering laboratory resource development endangered crude drug northwest china shaanxi normal university xian china college life science food engineering shaanxi xueqian normal university xian china college life science food engineering shaanxi xueqian normal university xian china electronic address huawenpingcom key laboratory ministry education medicinal resource natural pharmaceutical chemistry national engineering laboratory resource development endangered crude drug northwest china shaanxi normal university xian china electronic address caoxiaoyansnnueducn

rosmarinic acid synthase essential enzyme involved biosynthesis rosmarinic acid ra facilitates coupling phenylpropanoid tyrosinederived pathway product study identified six smras gene salvia miltiorrhiza smras one functionally characterized date realtime quantitative pcr employed analyze expression profile smras gene family revealing smras predominantly expressed root medicinal component miltiorrhiza smras smras exhibited significant response abscisic acid aba gibberellin ga methyl jasmonate meja stimulus smras notable response ga meja glucuronidase gu staining transgenic arabidopsis thaliana confirmed spatiotemporal expression pattern smras consistent qrtpcr result smras primarily localized cytoplasm plasma membrane finding suggested overexpressions smras smras led increased level salvianolic acid b salb ra concomitant decrease danshensu ds content served substrate contrast rna interference line exhibited downward trend content substance interestingly significant change detected salb ra ds content due overexpression smras rna interference line collectively study demonstrated smras smras key regulator ra salb biosynthesis miltiorrhiza smrass role appears le impactful suggesting complex regulatory network influence medicinal property plant

copyright published elsevier bv

doi jgene

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

abstract dev biol nov online ahead print

pax transcription factor egl link egfr signaling assembly celltype specific apical extracellular matrix caenorhabditis elegans vulva

schmidt hf darwin cb sundaram mv

department genetics university pennsylvania perelman school medicine philadelphia pa usa department genetics university pennsylvania perelman school medicine philadelphia pa usa electronic address schmidthpennmedicineupennedu

update biorxiv sep

surface epithelial tissue covered apical extracellular matrix aecm aecms different tissue distinct composition serve distinct function yet particular cell type assembles proper aecm well understood used celltype specific matrix c elegans vulva investigate connection cell identity matrix assembly vulva epithelial tube composed seven cell type descending egfrrasdependent notchdependent lineage vulva aecm contains multiple zona pellucida domain zp protein common component aecms across life zp protein let cutl assemble cell surface noah assembles subset surface three zp gene broadly transcribed indicating celltype specific zp assembly must determined feature destination cell surface paired box pax transcription factor egl promotes assembly matrix prevents inappropriate assembly matrix suggesting egl promotes expression one zp matrix organizer result connect known signaling pathway various downstream effector eglpax expression zp matrix component vulva cell fate execution propose dedicated transcriptional network may contribute cellappropriate assembly aecm many epithelial organ

copyright published elsevier inc

doi jydbio

abstract j clin invest nov e

cell receptor rascue cancer

tran e

comment natural tcrs targeting krasgv display fine specificity sensitivity human solid tumor

treatment cell genetically engineered express tumorreactive cell receptor tcrs known tcrgene therapy tcrt promising immunotherapeutic approach patient cancer identification optimal tcrs use tumor antigen target key consideration tcrt issue jci bear colleague report use vitro assay characterize four hlaa hlaarestricted tcrs targeting oncogenic kras gv mutation tcrs derived healthy donor patient pancreatic cancer received vaccine mutant kras promising tcrs warrant testing patient kras gvpositive cancer

doi jci pmcid pmc indexed medline

conflict interest statement conflict interest et member scientific advisory board turnstone biologics consultant astrazeneca pathfinder oncology et received research funding kuni foundation et also inventor patent antikrasgd cell receptor u antikrasgd cell receptor u antikrasgd cell receptor u pending patent antikrasgd cell receptor u

abstract re sq preprint oct rsrs doi rsrsv

targeting galectinras interaction treating malignant peripheral nerve sheath tumor

wang hc torres k xia r malogolowkin hsu sw chen ch shih tc

background neurofibromatosis type nf common inherited neurological disorder lead development malignant peripheral nerve sheath tumor mpnsts highly aggressive form sarcoma current treatment option mpnsts limited poor prognosis high recurrence rate study aim explore potential targeting galectin gal ra interaction novel therapeutic strategy mpnsts method molecular docking simulation conducted identify specific residue involved gal hrasgv interaction lls compound designed target ra binding pocket gal developed tested efficacy lls evaluated vitro assay including cell viability apoptosis coimmunoprecipitation study well vivo assay using orthotopic mpnst xenograft experimental lung metastasis model transcriptome sequencing performed analyze impact lls gene expression signaling pathway result molecular docking revealed key residue involved galras interaction lls shown bind residue disrupting interaction lls treatment resulted ra delocalization plasma membrane suppression raserk signaling pathway vitro lls significantly reduced mpnst cell proliferation induced apoptosis vivo lls demonstrated potent antitumor activity reducing tumor burden metastasis improving survival animal model transcriptome analysis showed lls downregulates critical pathway including kras signaling epithelialmesenchymal transition emt conclusion interference galras interaction could lead suppression ra signaling pathway lls effectively disrupts galras interaction resulting significant antitumor antimetastatic effect mpnst model finding indicated targeting gal lls offer promising therapeutic approach treating mpnsts may also applicable malignancy gal ra key oncogenic driver

doi rsrsv pmcid pmc

abstract adv sci weinh nov e online ahead print

endosomal trafficking bypassed rabbcd interplay promotes axonogenesis krasmutant pancreatic cancer

zhang luo lin fang z zheng h xie q wu z yu c yang j yu chen c chen r

school medicine south china university technology guangzhou guangdong p r china department pancreatic surgery guangdong provincial people hospital guangdong academy medical science guangzhou guangdong p r china department urology sun yatsen memorial hospital sun yatsen university guangzhou guangdong p r china guangdong provincial key laboratory malignant tumor epigenetics gene regulation sun yatsen memorial hospital state key laboratory oncology south china guangzhou guangdong p r china second school clinical medicine southern medical university guangzhou guangdong p r china

perineural invasion pni represents unique biological feature associated poor prognosis pancreatic ductal adenocarcinoma pdac especially presence kras mutation extracellular vesicle evpackaged circular rna circrnas function essential mediator tumor microenvironment communication triggering pdac cell invasion distant metastasis however regulatory mechanism evpackaged circrnas pni krasmutant pdac yet elucidated herein krasgd mutationresponsive evpackaged circrna circpnit positively correlated pni pdac patient identified functionally krasgd pdacderived evpackaged circpnit promoted axonogenesis pni vitro vivo mechanistically circpnitmediated rabbcd interplay bypassed traditional endosomal trafficking anchor rabb lipid raft multivesicular body packaged circpnit cd ev subsequently cd ev delivered circpnit neuron binding trpv facilitating dscaml transcriptioninduced axonogenesis turn enhanced pni activating gfrret pathway importantly circpnitloaded cd ev established dramatically promote pni krasgd trprh pdxcre mouse model collectively finding highlight mechanism underlying evpackaged circrnas mediate pni krasmutant pdac cell rabb endosomal bypass identifying circpnit effective target treatment neurometastatic pdac

author advanced science published wileyvch gmbh

doi advs

abstract sci rep nov

association kras mutation alcohol consumption brazilian patient colorectal cancer

gomesfernandes b trindade lm de castro bastos rodrigues cardoso jpd lima ft rogerio l de vasconcelos generoso carneiro jg da silva rg de souza rp de marco l bastosrodrigues l

centro de tecnologia em medicina molecular faculdade de medicina universidade federal de mina gerais belo horizonte mina gerais brazil departamento de nutrio universidade federal de mina gerais belo horizonte mina gerais brazil faculdade de medicina cincias mdicas de mina gerais belo horizonte mina gerais brazil hospital da clnicas universidade federal de mina gerais belo horizonte mina gerais brazil laboratrio personal diagnsticos de preciso clnica personal belo horizonte mina gerais brazil laboratrio de biologia integrativa grupo de pesquisa em bioestatstica e epidemiologia molecular universidade federal de mina gerais belo horizonte mina gerais brazil departamento de cirurgia universidade federal de mina gerais belo horizonte mina gerais brazil centro de tecnologia em medicina molecular faculdade de medicina universidade federal de mina gerais belo horizonte mina gerais brazil lubastosrgmailcom departamento de nutrio universidade federal de mina gerais belo horizonte mina gerais brazil lubastosrgmailcom

colorectal cancer crc leading cause morbidity mortality worldwide detection metastasis efficient treatment disease significantly improve patient survival quality life however limitation diagnosis postoperative surveillance associated low crc detection survival rate thus project aimed evaluate molecular profile patient diagnosed crc molecular biomarkers constitute new frontier diagnosis treatment prognosis method result patient included study predominantly male median age year sd min max majority primary tumor located rectum sigmoid ascending colon evaluated gene kras nra braf egfr tp using sanger sequencing somatic germline mutation found kras egfr tp gene common somatic alteration r kras variant also strongly associated alcoholism p furthermore patient somatic mutation tp significantly higher mortality compared wildtype allele ci conclusion finding support relationship alcohol consumption r mutation classified pathogenic colorectal cancer thus study investigating link alcohol consumption colorectal carcinogenesis tumor progression ought conducted

author

doi pmcid pmc indexed medline

conflict interest statement author declare competing interest

abstract dokl biochem biophys oct online ahead print

effect overexpression specific subunit sayp bap chromatin remodeling complex drosophila melanogaster

chmykhalo vk shidlovskii yv lebedeva la schedl p giordano e

institute gene biology russian academy science laboratory gene expression regulation development moscow russia vkchmykhaloicloudcom institute gene biology russian academy science laboratory gene expression regulation development moscow russia princeton university princeton usa universit di napoli federico ii naples italy

phenotypic manifestation increased expression bap ey sayp gene melanogaster analyzed using wing disc model show moderate coexpression bap ey gene wing disc lead abnormality wing veining probably caused suppression egfrrasmapk signaling pathway strong induction coexpression gene wing disc lead complete suppression wing development adult ubiquitous coexpression bap ey lethal st instar larval stage lead formation melanotic tumor phenotype observed exclusively bap ey coexpressed evidence suggests robust synergistic effect combined action gene manifested hyperactivity cell proliferation differentiation

pleiades publishing ltd

doi sx

abstract gene oct online ahead print

gene expression profiling maslinic acidtreated mcf breast cancer cell using nanostring ncounter pancancer pathway panel

tan sy foo cn ng fl tan ch lim ym

centre cancer research kandiah faculty medicine health science universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia centre cancer research kandiah faculty medicine health science universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia department population medicine universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia centre cancer research kandiah faculty medicine health science universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia department chinese medicine universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia quiliniq lifesciences sdn bhd unit menara oval damansara taman tun dr ismail kuala lumpur malaysia centre cancer research kandiah faculty medicine health science universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia department preclinical science universiti tunku abdul rahman bandar sungai long cheras kajang selangor malaysia electronic address ymlimutaredumy

breast cancer remains significant global health concern impacting million woman every year maslinic acid pentacyclic triterpene found exert promising anticancer effect various cancer including breast cancer yet underlying mechanism remain unclear study aim elucidate anticancer property via gene expression profile breast cancer cell cytotoxicity assay result revealed mcf exerts highest sensitivity h treatment followed td mdamb mcf selected indepth analysis using nanostring ncounter pancancer pathway panel analyze differential expression gene degs across three time point h significant degs identified upregulated downregulated silico analysis indicated degs involved pathway cancer focal adhesionpikmtor signaling pathway pikakt ra signaling pathway regulation degs contributes several cellular activity apoptosis inhibition cell proliferation cell cycle survival reduction glycolysis angiogenesis dna repair additionally unfolded protein response emerged noteworthy biological process study study unravels molecular mechanism underpinning therapeutic potential breast cancer

copyright published elsevier bv

doi jgene

conflict interest statement declaration competing interest author declare known competing financial interest personal relationship could appeared influence work reported paper

